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SUMMARY  
 
Signal transduction pathways are important for the cell to transduce external or internal 
stimuli where second messengers play an important role as mediators of the stimuli.  One 
important group of second messengers are the phosphoinositide family present in 
organisms ranging from yeast to mammals.  The dephosphorylation and phosphorylation 
cycle of the phosphatidylinositol species are thought to be important in signaling for 
recruitment or activation of proteins involved in vesicular transport and/or to control the 
organization of the actin cytoskeleton.  In mammals, phosphatidylinositol (4,5)-
bisphosphate (PI(4,5)P2) signaling is essential and regulated by various kinases and 
phosphatases.  In the model organism Saccharomyces cerevisiae PI(4,5)P2 signaling is also 
essential but the regulation remains unclear.  My dissertation focuses on the regulation of 
PI(4,5)P2 signaling in Saccharomyces cerevisiae. 
The organization of the actin cytoskeleton in Saccharomyces cerevisiae is regulated by 
different proteins such as calmodulin, CMD1, and here I present data that CMD1 plays a 
role in the regulation of the only phosphatidylinositol 4-phosphate 5-kinase, MSS4, in 
Saccharomyces cerevisiae.  CMD1 regulates MSS4 activity through an unknown 
mechanism and thereby controls the organization of the actin cytoskeleton.  MSS4 and 
CMD1 do not physically interact but MSS4 seems to be part of a large molecular weight 
complex as shown by gel filtration chromatography.  This complex could contain regulators 
of the MSS4 activity.  The complex is not caused by dimerization of MSS4 since MSS4 
does not interact with itself. 
Two pathways, the cell wall integrity pathway and TORC2 (target of rapamycin complex 2) 
signaling cascade are important for the organization of the actin cytoskeleton.  Loss of 
TOR2 function results in a growth defect that can be suppressed by MSS4 overexpression.  
To further characterize the link between MSS4 and the TORC2 signaling pathway and the 
cell wall integrity pathway we looked for targets of PI(4,5)P2.  The TORC2 pathway and 
the cell wall integrity pathway signal to the GEF ROM2, an activator of the small GTPase 
RHO1.  In our study we identified ROM2 as a target of PI(4,5)P2 signaling.  We observed 
that the ROM2 localization changes in an mss4 conditional mutant.  This suggests that the 
proper localization needs PI(4,5)P2.  This could be mediated by the putative PI(4,5)P2 
binding pleckstrin homology (PH) domain of ROM2. 
 
_________________________________________________________________________ 
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 To better understand the regulation of PI(4,5)P2 levels in Saccharomyces cerevisiae we 
focused on one of the PI(4,5)P2 5-phosphatases, INP51.  Here we present evidence that 
INP51 is a new negative regulator of the cell wall integrity pathway as well as the TORC2 
pathway.  INP51 probably regulates these two pathways by the turnover of PI(4,5)P2 
thereby inactivating the effector/s.  The deletion of INP51 does not result in any phenotype, 
but when combined with mutations of the cell wall integrity pathway we observe synthetic 
interaction.   
INP51 together with the GTPase activating protein (GAP) SAC7, responsible for the 
negative regulation of RHO1, negatively regulates the cell wall integrity pathway during 
vegetative growth.  One of the targets of cell wall integrity pathway, the cell wall 
component chitin, which is normally deposited at the bud end, bud neck and forms bud 
scars, is delocalized in the mother cell in the sac7 inp51 double deletion mutant.  In 
addition, another downstream component of the cell wall integrity pathway, the MAP 
kinase MPK1, has increased phosphorylation and protein level in the sac7 inp51 double 
deletion mutant.  This suggests that INP51 is important for the negative regulation of the 
cell wall integrity pathway. 
Furthermore, we show evidence that INP51 forms a complex with TAX4 or IRS4, with two 
EH-domain containing proteins, that positively regulates the activity of INP51 and in this 
manner negatively regulate the cell wall integrity pathway.  The EH-domain is known to 
bind the NPF-motif.  This motif is present in INP51 and is important for INP51 interaction 
with TAX4 or IRS4.  The EH-NPF interaction is a conserved mechanism to build up 
protein networks.  The interaction between an EH-domain containing protein and a 
PI(4,5)P2 5-phosphatase is conserved.  This is demonstrated by the epidermal growth factor 
substrate EPS15 (EH) interaction with the PI(4,5)P2 5-phosphatase synaptojanin the 
mammalian orthologue of the Saccharomyces cerevisiae INP proteins. 
In summary, INP51 together with TAX4 and IRS4, forms complexes important for 
regulation of PI(4,5)P2 levels.  The complexes are linked to the TORC2 signaling pathway 
and the cell wall integrity pathway, specifically regulating MPK1 activation and chitin 
biosynthesis.  The work presented in this dissertation facilitates the development of a model 
of the complex regulation of PI(4,5)P2 signaling in Saccharomyces cerevisiae. 
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1.  INTRODUCTION 
 
1.1    Phosphoinositides and phosphoinositide-binding modules 
 
Cells transduce external or internal stimuli through different signaling mechanisms.  
Stimuli can be transduced by protein modification such as phosphorylation, prenylation or 
palmitoylation and by second messengers such as phosphoinositides to change the activity 
status of a protein.  Protein modifications take place on conserved motifs within the target 
protein and are often carried out by specific enzymes.  One well-studied example of protein 
modification is the prenylation of the RAS protein in mammalian cells.  The RAS protein 
contains a specific sequence that is recognized by an enzyme called farnesyl transferase 
protein.  Once RAS is prenylated, it can attach to the plasma membrane and function in 
signal transduction (1).  In addition, second messengers that bind the target protein through 
specific domains can mediate signal transduction.  Calcium (Ca2+) is a second messenger 
that increases in the cytosol upon stimuli such as hormonal activation and binds to specific 
domains like the C2 domain (2,3).  Another important group of second messengers acting 
analogous to Ca2+, is the lipid family which are involved in different cellular processes such 
as regulation of cell growth and of the organization of the actin cytoskeleton (4-6).   
 
1.1.1   Phospholipids involved in regulatory processes 
 
Lipids and their metabolites are known primarily to have an essential structural role 
involving the building up of membranes that build up a barrier between the cytoplasm and 
the external environment.  In addition, these molecules are responsible for compart- 
mentalization of a cell (7).  Lipids also have an essential role in regulatory processes such 
as phosphoinositide signaling the focus of this introduction (8).  Lipids are a diverse group 
of biological molecules some made up primarily of and others exclusively of nonpolar 
groups.  Lipids can be classified into three major groups: neutral lipids, phospholipids and 
steroids.  Neutral lipids are the major components of fats and oils used for storage {Alberts, 
2002 #341}.  The primary structural element of biological membranes is the phospholipid 
group that comprises phosphate-containing molecules with structures related to the 
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triglycerides and consist of phosphatidylcholine, phosphatidylethanolamine and 
phosphatidylinositol (PI) (Figure 1){Alberts, 2002 #341}.   
PI is the building block of a subgroup of the phospholipid family, the phosphoinositides 
(PPI) (Figure 2) that have become important in the past two decades since they have 
specific roles as second messengers (8).  PPI are produced in different compartments of the 
cell and play an important role in recruiting proteins via specific domains (9).  PPI are 
unique among second messengers because they can be rapidly modified by phosphorylation 
or dephosphorylation to induce or inhibit signaling (10). 
INOSITOL RING
DIACYLGLYCEROL
MOIETY
     
Figure 1 Chemical structure of phosphatidylinositol.  
Phosphatidylinositol is built up of an inositol ring linked to a diacelglycerol moiety that contains two fatty 
acid chains.  There are free hydroxyl group at positions 2-6 on the inositol head group. Only 
phosphoinositides phosphorylated at the 3’, 4’ and/or 5’ have been identified in mammalian cells (11). 
 
1.1.2  Synthesis of phosphatidylinositol and its derivatives, the  
phosphoinositides 
 
PI is the starting molecule for synthesis of PPI (Figure 1) that consists of an inositol ring 
(cyclic hexadydric alcohol) and the hydrophobic component diacylglycerol (DAG) moiety 
Figure 2).  The DAG moiety contains two fatty acid chains esterified onto glycerol which is 
in turn attached through a diester phosphate to the 1-hydroxyl of the inositol ring (12).  PPI 
is produced by phosphorylation thereby producing different PI species (13).   
PI is essential because Saccharomyces cerevisiae cells with mutations in the PIS1 gene 
encoding the phosphatidyltransferase responsible for generating PI (Figure 2) are not viable 
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(13,14).  The lethality is probably not due to an effect on membrane structure but rather due 
to its role in cellular signaling such as in the organization of the actin cytoskeleton and 
membrane trafficking (8). 
  
LPA PA CDP-DAG
PI
IPC
GPI
PPI
CDS1
PIS1
+CTP
+INS
Gly-3-P
Endoplasmatic
reticulum
Glu-6-P
Plasma membranevacuole
INS-1-P
INO1
nucleus
 
Figure 2 The biosynthesis of phosphatidylinositol  
Gly-3-P is used to generate LPA and further PA.  CTP is introduced into PA by CDS1 (localized in the ER) to 
yield CDP-DAG that in turn is the substrate of PIS1 (localized in the ER) that generates phosphatidylinositol 
(PI).  PI can be further processed in three branches. PI is used in the biosynthesis of GPI initiated by the 
transfer of N-acetylglucosamine to phosphatidylinositol. The AUR1 protein catalyzes the reaction in which 
inositol phosphate is transfered from phosphatidylinositol to IPC in the Golgi.  The third branch is the 
phosphatidylinositols phosphorylated at different locations of the cell. Glycerol-3-phosphate (Gly-3-P); 
lysophosphatidic acid (LPA); phosphatidic acid (PA); cytidine diphosphate-diacylglycerol (CDP-DAG); 
phosphatidylinositol (PI); glycosyl phosphatidylinositol (GPI); phosphorylated phosphatidylinositol (PPI) and 
inositol phosphate ceramide (IPC). Modified from (8) 
 
For the synthesis of PI, glycerol-3-phosphate (Gly-3-P) undergoes two steps of processing 
to yield phosphatidic acid (PA).  PA is then used as the substrate of cytidine 5-
bisphosphate-diacylglycerol (CDP-DAG) synthase (CDS1) to produce CDP-DAG (13,15).  
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This is followed by the transfer of CDP-DAG to the inositol ring to produce PI that is 
modified further by phosphorylation (Figure 1 and 2).  In addition, PI is also used for 
glycosylphoshpatidylinositol and sphingolipid synthesis (14). 
The inositol ring can be phosphorylated and dephosphorylated by different but specific 
kinases and phosphatases yielding a wide combination of signaling molecules. These 
species (PPI) are the result of differential phosphorylation on the 3’, 4’ and 5’ position of 
the inositol ring (Figure 1).  There are five phosphoinositide species in Saccharomyces 
cerevisiae: phosphatidylinositol (3)-phosphate (PI(3)P), phosphatidylinositol (4)-phosphate 
(PI(4)P), phosphatidylinositol (3,5)-bisphosphate (PI(3,5)P2) and phosphatidylinositol 
(4,5)-bisphosphate (PI(4,5)P2).  In mammalian cells two additional species, 
phosphatidylinositol (5)-phosphate (PI(5)P) and phosphatidylinositol (3,4,5)-trisphosphate 
(PI(3,4,5)P3), exist (16). 
The first example of phosphoinositide signaling was the generation of the second 
messengers inositol 1,4,5 trisphosphate (IP3) and diacylglycerol (DAG) by hydrolysis of 
PI(4,5)P2 (6).  It was later established that PI(4,5)P2, the main focus in this introduction, 
and other PPI are used directly for regulatory functions (17). PPI mediate their function by 
forming membrane-binding sites for soluble proteins that contain specific PPI-binding 
modules. 
 
1.1.3    Phosphoinositide signaling mediated by phosphoinositide-binding 
domains 
 
The phosphoinositide-binding domains such as the pleckstrin homology (PH) domain are 
conserved from yeasts to mammals.  However, there are few cases where PPI binds 
proteins independently of known phosphoinositide-binding domains such as actin-
associated proteins that bind PI(4,5)P2 through electrostatic interaction using clusters of 
positively charged residues (18,19).   
The identification of lipid binding domains has made it possible to elucidate the function of 
the different PPI and the cellular processes where PPI is involved.  The specificity of each 
phosphoinositide is based also on its structure and localization (9).  PPI are involved in 
recruiting proteins, stabilizing protein complexes or activating membrane proteins and their 
synthesis takes place at different cellular locations such as the plasma membrane and the 
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nucleus (6,9,10,16,20).  The same domains that bind PPI in cytosolic proteins are also 
present in nuclear proteins where equivalent signaling via PI(4,5)P2 takes place (21).  PPI 
have been implicated in a diverse range of functions, from signal transduction (e.g. insulin 
signaling), regulation of GTPases and their cofactors in vesicle budding, endosome fusion, 
cytoskeletal reorganization to differentiation, cell survival and platelet activation 
(9,10,22,23). 
The different phosphoinositide-binding domains generally bind a specific phosphoinositide 
and are distinct in structure, such as the PX-domain that only binds PI(3)P, but comparison 
studies show that they do share common features such as a positively charged binding core.  
The PPI interaction is generally weak allowing a flexible association to the protein.  It is 
believed that this mechanism could allow a local enrichment or translocation of the specific 
target protein upon increased phophoinositide production (24).   
 
1.1.3.1  PI(4,5)P2-binding modules. 
 
The first domain shown to bind a phosphoinositide, PI(4,5)P2 in this case, was the 100 
amino acid long pleckstrin homology (PH) domain found in pleckstrin the major substrate 
of protein kinase C in platelets (25).  The PH domain is mainly found in proteins involved 
in the regulation of the actin cytoskeleton.  The group of PH domains (approximately 250 
in the human proteome and 25 in Saccharomyces cerevisiae) are not homologous and are 
found to have various specificities (10).  PH domains have not only been shown to bind PPI 
but also inositol polyphosphates.  Furthermore in some cases the PH domains have been 
shown to be involved in protein-protein interactions (26).  In vitro experiments show that 
the PH-containing proteins can be divided into different groups depending on their 
phosphoinositide specificity.  PH domains can bind PI(3,4,5)P3, PI(4,5)P2 and PI(3,4)P2.  
Interestingly, only a minority of the existing PH domains bind a particular PPI with high 
affinity.  One reason could be that PI(4,5)P2 is more abundant and does therefore not 
require stringent affinity (10).  However, in general the function of the PH domain is 
phosphoinositide-dependent.  Even if the PH domains are a heterogenous group on the 
amino acid sequence level but interestingly the three-dimensional structures of known PH 
domains are highly conserved (18). 
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PH domains are found in signaling molecules such as protein kinases, phospholipases and 
positive regulators of small GTPases such as GEF involved in the organization of the actin 
cytoskeleton (27).  Interestingly, not only guanine nucleotide exchange factors, positive 
regulators of small GTPases, are regulated by binding to PPI but also the GTPase activating 
proteins the negative regulators of small GTPases (22,28,29).   
The ENTH (epsin N-terminal homology) domain is an additional PI(4,5)P2 binding domain 
and is mainly found in proteins involved in endocytosis (30).  In mammalian cells, the 
HIPR1 (Huntingtin interacting-protein related protein 1) contains an ENTH and an actin-
binding module.  It localizes to clathrin-coated vesicles suggesting a link between 
endocytosis and the actin cytoskeleton (24).  In contrast, the ENT3 protein in 
Saccharomyces cerevisiae involved in protein sorting binds PI(3,5)P2 through its ENTH 
domain adding more complexity to suggested specific PI(4,5)P2-binding proteins (31).  
Another newly identified PI(4,5)P2-binding domain is the postsynaptic density (PDZ) 
domain implicated in regulating the assembly of multiprotein complexes at the cell 
membrane (30).   
Furthermore, PI(4,5)P2 has been shown to modulate the activity of ion channels in 
mammalian cells but the binding domain has not been described (32).  PI(4,5)P2 has been 
suggested to either bind directly to the channel to modulate activity or alter local membrane 
topology by electrostatic interactions (11). An additional PH domain independent signalling 
is exemplified by Arp2/3 complex involved in promoting actin polymerization that is 
regulated by the WASP family (18,19).  PI(4,5)P2 stimulates the Wiskott-Aldrich syndrome 
protein (WASP) synergistically with CDC24 signaling and SH3-containing adapter proteins 
(19).  Interestingly, WASP has a PH-like domain but it is a lysine-rich basic region that 
most likely mediates the phosphoinositide binding (33).  
 
1.1.3.2   The FYVE domain and PX domain 
 
Membrane targeting can also be mediated by PI(3)P and PI(3,5)P2 through the FYVE and 
the PX domains. 
The FAB1/YOTB/VAC1/EEA1 (FYVE) domain is important for the regulation of vesicle-
mediated protein transport and binds PI(3)P with high specificity  and has not been 
observed to bind other PPI (26,34).  The high binding affinity of PI(3)P is achieved by 
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head-group interaction but requires a stabilization through membrane association and/or 
oligomerization (10).  The human early endosomal antigen (EEA1) concentrates at early 
endosomes in part through specific binding of its FYVE domain to PI(3)P (35,36).  In 
Saccharomyces cerevisiae the FYVE domain is present in proteins involved in vesicular 
trafficking.  One example is the FAB1 protein, a PI (3)-P 5-kinase that contains a central 
FYVE domain that might recruit FAB1 to the endosomal fraction rich in PI(3)P substrate.  
Furthermore, the FYVE domain has been linked to the actin cytoskeleton which is 
exemplified by the frabin protein also involved in endosomal trafficking (37). 
The phlox (phagocyte oxidase) homology (PX) domain also known as PB2 (phlox and 
Bem1p 2) domain, is associated with signaling and membrane trafficking (27). The PX 
domain plays in most cases a membrane targeting role binding PI(3)P in a similar way as 
the FYVE domain observed in p40phox subunit of the phagocyte NADPH oxidase. The 
NADPH oxidase responds to PI 3-kinase signaling in neutrophil function and inflammation 
by producing reactive oxygen species (ROS) (38).  In the p47phox subunit of the NADPH 
oxidase the PX domain binds PI(3,4)P2 (27,38).  The PX domain has also been observed as 
a protein-protein interaction module.  The same PX domain in p47phox is able to interact 
with the SH3 domain from the same protein (39).  The dual interaction to SH3 and PPI 
might reflect a mode of regulation.  The PX domain also occurs in proteins involved in 
membrane trafficking, such as sorting nexus and in the yeast vacuole protein VAM7 
(40,41).  The polarity establishment proteins BEM1 and BEM3 in budding yeast contain 
the PX domain regulating the localization (42). 
In addition to domains specifically binding to PI(3)P there is evidence for new motifs for 
lipid-protein interaction.  The yeast protein ETF1 binds PI(3)P but does not contain a 
previously characterized PPI-binding motif but contains a K113KPAKK118 sequence that 
might be important for phosphoinositide binding.  ETF1 has been suggested to be a specific 
VPS34 effector involved in autophagy (43). 
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1.2  Phosphoinositide synthesis, turnover and function in higher 
eukaryots  
 
PPI binding to different proteins is controlled by specific kinases and phosphatases that 
regulate the PPI levels.  The synthesis and turnover of PPI are well characterized in 
mammalian cells where most enzymes exists as a variety of isoforms with diverse functions 
in different cell types (6).  Their essential role has been proven by the fact that mutations in 
enzymes involved in phosphoinositide signaling have been implicated in human diseases 
(34).  Therefore, the regulation of PPI signaling is very important.  PPI levels can be 
regulated by phosphatases that specifically remove the 3’, 4’ and 5’ phosphates on the 
inositol ring (14).  Furthermore, PI(4,5)P2 signaling can be inhibited by hydrolysis 
mediated by phospholipase C.  
 
1.2.1  PI(3,4,5)P3 and the insulin signaling pathway  
 
In mammals, three classes of phosphatidylinositol 3-kinase (PI 3-K) enzymes exist (class I, 
II and III) (Figure 3).  They are mainly involved in growth regulation but also in other 
cellular processes (11).  The class I enzymes use PI, PI(4)P or PI(4,5)P2 as substrate in 
vitro.  In vivo they mainly produce PI(3,4)P2 and PI(3,4,5)P3 where PI(3,4)P2 could be the 
result of the action of a 5-phosphatase on PI(3,4,5)P3.  Class II enzymes phosphorylate PI 
and PI(4)P.  Class III can only phosphorylate PI and it is thought to be involved in 
membrane trafficking (11,44).   
In the insulin signaling pathway (Figure 4), the Class I PI 3-kinase responds to insulin by 
converting the plasma membrane lipid PI(4,5)P2 to PI(3,4,5)P3 (45).  PI(3,4,5)P3 then binds 
to the PH domain of one of the major targets of PI 3-kinase signaling, the Akt protein (also 
known as protein kinase B (PKB)).  The importance of the Akt PH domain for activation 
depends on the cell type and/or the stimulus.  Interestingly, activation of the PI 3-K/Akt 
pathway has been implicated in the prevention of apoptosis in several cell types (46).  
Additional studies, has implicated PI 3-K deregulation in various cancers (47).  Regulation 
of the PI 3-K signaling is therefore important to avoid improper signaling.  Turnover and 
regulation of PI 3-K products is mediated by two phosphatases PTEN and SHIP1/2.   
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Figure 3 Phosphoinositide synthesis in mammalian cells. 
Black arrow indicates production of phosphoinositide (phosphorylation by indicated kinases). In squares are 
the different phosphoinositide species. The phosphoinositide PI(4,5)P2 can be further processed by 
phospholipase C (PLC) yielding DAG and IP3.  IP3 can be further phosphorylated to produce inositol 
polyphosphates here refered as IPP. Modified from (11) 
 
PTEN (for phosphatase and tensin homolog deleted on chromosome ten) is a PI(3,4,5)P3 3-
phosphatase which was originally isolated as a tumour-suppressor gene in breast cancer and 
glioblastoma.  There are some studies suggesting that PTEN also use inositol 1,3,4,5,6-
pentakisphosphate (IP5) as substrate and as well as being a protein phosphatase but the 
biological function remains unclear (47,48).  The role of PTEN in the insulin signaling 
pathway is well characterized where the product of PI 3-K, PI(3,4,5)P3, is dephosphorylated 
regenerating PI(4,5)P2 (Figure 4).  This results in the release of AKT from the plasma 
membrane which then is not able to perform its function (14,49).   
INTRODUCTION 
_________________________________________________________________________ 
_________________________________________________________________________ 
10 
Phosphatidylinositol 3-kinase (PI 3-K) 
signalling in mammalian cells
PI(4,5)P2 PI(3,4,5)P3
PI 3-K
PTEN
AktPDK1
Insulin
receptor
Transcription
Translation
SHIP1/2
PI(3,4)P2
 
Figure 4 The PI 3-kinase signaling cascade.  
Upon stimulation by growth factors such as insulin the tyrosine kinase receptor activates PI 3-K.  PI(4,5)P2 is 
converted to PI(3,4,5)P3 by PI 3-K. This can be counteracted by the 3-phosphatase PTEN regenerating 
PI(4,5)P2. The PH domain containing Akt and PDK1 are activated by PI(3,4,5)P3 to further regulate 
transcription and translation. The PI(3,4,5)P3 can be dephosphorylated by the 5-phosphatases SHIP1/2 at the 
5’ position to yield PI(3,4)P2. 
 
Different PTEN mutations or silencing have been implicated in various cancers probably 
due the hyperactivation of the insulin pathway (45:Vivanco, 2002 #265).  This indicates the 
importance of proper regulation of the temporal lipid-protein interaction (47).  
In addition to PTEN, the Src-homology-2 (SH2)-containing inositol 5-phosphatases, SHIP1 
and SHIP2, dephosphorylate PI(3,4,5)P3 produced by PI 3-K (insulin pathway) at the 5’ 
position possibly yielding another potential second messenger PI(3,4)P2 (47).  SHIP1 is a 
hematopoetic-restricted enzyme and mutations in SHIP1 has been implicated in myeloid 
leukaemia (34).  SHIP2 is ubiquitously expressed.  However, mutations have primarily 
been implicated in genetic susceptibility to type 2 diabetes (34,50). 
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1.2.2  Regulation of PI(4,5)P2 signaling by RHO GTPases and phosphatases, 
and the role of PI(4,5)P2 in the regulation of the actin cytoskeleton and 
in membrane trafficking 
 
PI(4,5)P2 is mainly synthesized at the plasma membrane, accounts for approximately 1% of 
lipid molecules in the plasma membrane and is thus one of the more abundant PPI in the 
cell (10,51).  The synthesis of PI(4,5)P2 in mammalian cells is complex because it can be 
produced by either PI 5-P 4-kinase (PIP4K) or PI 4-P 5-kinase (PIP5K) (Figure 3).  
Furthermore they exist as different isoforms such as PIP5K α, –β and -γ as well as different 
splice variants (11:Yin, 2003 #99,52,53).  However, PIP4K and PIP5K are not functionally 
redundant (24).  The PIP4K is classified into PIP4K-α and PIP4K-β and are functionally 
non-redundant (11).  PIP4K localizes to the cytosol, to the nucleus and to the endoplasmic 
reticulum but the physiological function of PIP4K is not well understood. 
PIP5K variants also localizes to distinct cell compartments such as to the plasma 
membrane, at focal adhesions, to the nucleus and to the Golgi yielding different pools of 
PI(4,5)P2 (53).  PI(4,5)P2 plays an important role in the regulation of the actin cytoskeleton 
but also in exocytosis, endocytosis and ion channel regulation (19,24,53).  
In mammalian cells, most phosphoinositide species are not detectable in unstimulated cells 
but rapidly accumulate after stimulation with various agonists (44).  in contrast, PI(4,5)P2 is 
primarily maintained at relatively constant levels in cells but changes are observed upon 
specific stimulation (53-55).  Upon postsynaptic activity PI(4,5)P2 production is increased 
and has been linked to endocytosis at the presynaptic terminus (56).  In mammalian cells, 
the RHO family of small GTPases are important for the regulation of PI(4,5)P2 (18).  
PIP5K activity is induced by the RHO-GTPases Rac1, RhoA and ARFs involved in the 
organization of the actin cytoskeleton and in membrane trafficking (57-59).  
Inactivation of PIP5K signaling has been suggested to be performed by casein kinase I-
dependent phosphorylation that has been observed both in mammalian cells and in 
Schizosaccharomyces pombe (53).  However, inhibition of PI(4,5)P2 signaling is primarily 
mediated by specific PPI 5-phosphatases (14). 
One important PI(4,5)P2 5-phosphatase is the OCRL1 (oculocerebrorenal Lowe) protein 
Interestingly, OCRL1 contains a central phosphoinositide 5-phosphatase domain and a 
RHO-GAP homology domain that interacts with the RHO-GTPase RAC (60,61).  
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Mutations in OCRL1 have been found to cause the oculocerebrorenal syndrome of Lowe 
leading to defects in epithelial cells in lens and kidney, and to mental retardation (19,62).  
OCRL1 localizes to the trans-Golgi network (TGN) and possibly to the lysosomes (60,62).  
TGN is the major sorting site involved in protein transport to the apical or basolateral parts 
in epithelial cells.  Mutations in OCRL1 gene, increasing PI(4,5)P2, has been suggested to 
lead to defective Golgi trafficking and abnormal delivery of lysosomal enzymes causing 
symptoms observed in the disease of Lowe syndrome (34,63).  Furthermore, OCRL1 
mutant cells are affected in the distribution of actin–binding proteins and have decreased 
long actin stress fiber (61).  
Synaptojanin 1 belongs to the family of PI(4,5)P2 5-phosphatases with a three-domain 
structure including a N-terminal domain with homology to the Saccharomyces cerevisiae 
protein SAC1, a catalytic domain and a C-terminal domain rich in proline (64).  The 
regulation of PI(4,5)P2 by synaptojanin has been implicated in rearrangements of actin 
filaments  (65).  In addition, synaptojanin 1 regulates the transport of clathrin-coated 
vesicles in neurons through the turnover of PI(4,5)P2  (19,66).  Synaptojanin 1 is recruited 
by endophilin to presynaptic terminals where it terminates the PI(4,5)P2-dependent clathrin 
coating which is followed by internalisation of the vesicle and uncoating producing an early 
endosome (67-69).  Mutations of synaptojanin 1 is lethal and the neurons of mutant animals 
contain an unusual high amount of clathrin-coated vesicles and actin filaments in the 
endocytic zone suggestive of an increased endocytosis probably due to increased levels of 
PI(4,5)P2 (70).  In contrast, overexpression reduces actin stress fibers (19).  Synaptojanin 1 
interacts with several proteins through distinct interaction modules.  EPS15 (Epidermal 
growth factor pathway substrate 15) interacts via its EH-domain with the NPF motif of 
synaptojanin (71).  EPS15 seems to play a role in endocytosis where EH-NPF interaction 
seems to be important for signaling networks (72).  Synaptojanin also interacts, probably 
through the proline rich C-terminal domain, with the SH3 domain of adaptor protein GRB2 
involved in the organization of the actin cytoskeleton (65,73,74).   
The action of PIP5K and the phosphatases, OCRL1 and synaptojanin 1, are primarily 
regulating the organization of the actin cytoskeleton and membrane trafficking.  Several 
components of these two cellular processes have been found to bind PI(4,5)P2 regulating 
their localization or activity. 
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1.2.2.1  The regulation of the actin cytoskeleton by PI(4,5)P2 
 
In response to extracellular signals cells move, change shapes and translocate organelle 
with the help of a dynamic actin cytoskeleton (44).  Actin remodelling is important for 
various processes such as the formation of filopodia, lamellipodia, membrane ruffles, 
phagosomes and endocytosis (24,53).  Actin cytoskeleton remodelling is important in cell 
motility in different cell types such as neutrophils, macrophages, platelets and in the 
nervous system (53,75).  The dynamic character is accomplished through the action of 
specific proteins and other molecules like PPI that regulate assembly/disassembly of the 
actin structure (18,44,76).  Cytoskeletal proteins were one of the first shown targets of PPI 
binding and regulation.  It was also observed that increased PI(4,5)P2 synthesis initiates 
actin assembly and depletion of PI(4,5)P2 triggers actin depolymerization (19). 
Actin is present in the cell both as monomeric form, globular actin (G-actin) and as 
filamentous actin (F-actin).  An important regulatory step is the inhibition of actin severing 
and capping.  This inhibition promotes actin polymerization which is in part controlled by 
PI(4,5)P2 (19).  Proteins regulating actin dynamics can be organized in four groups.   
The first group involves sequestration (binding) of G-actin by certain proteins such as 
profilin.  It inhibits spontaneous nucleation of actin and polymerization of F-actin.  The 
function of profilin is complex and different studies have suggested either inhibiting or 
stimulating roles (77).  Profilin forms complex with ATP-G actin and can associate with the 
barbed end maybe speeding up the nucleation process (78).  Actin will be fully incorporated 
(leading to assembly of actin filaments) when profilin dissociates from the barbed end.  
Increased amounts of PI(4,5)P2 lead to extensive actin polymerisation (79).  The 
mechanism by which PI(4,5)P2 promotes actin polymerization could be the dissociation of 
the profilin-actin interaction shown in in vitro (19,34).  Additionally, this PI(4,5)P2 induced 
actin polymerization has been suggested to alter membrane ruffling.  Intriguingly, the 
binding of PI(4,5)P2 to profilin has also been suggested to inhibit hydrolysis of PI(4,5)P2 by 
PLC (80).   
The second group regulating actin dynamics comprises proteins involved in actin 
polymerization controlled by various reversibly capping proteins, gelsolin/villin family and 
CapZ family that bind the barbed ends of F-actin preventing elongation (81,82).  Capping 
protein can also accelerate nucleation of new filaments from subunits by binding to small 
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oligomers.  Rac and phosphoinositides regulate release of capping proteins (gelsolin/villin 
family of severing and/or capping proteins and the CapZ family or ADF/cofilin family 
proteins) from the barbed ends of actin filaments, allowing polymerization of the F-actin 
(82).  Arp2/3 complex and associated factors seem to cap pointed ends and nucleate actin 
filaments of the sides of pre-existing filaments to form a branched network of actin 
important for cell motility (78).   
The third group regulating actin dynamics consists of some ADF/cofilin and gelsolin family 
members that sever and/or cap actin filament and appear to accelerate depolymerization 
from the pointed ends (83).  Cofilin binds Ca2+ independently of monomeric actin (G-actin) 
and filamentous actin (F-actin) in a 1:1 molar ratio.  It severs and depolymerizes F-actin in 
a pH-dependent manner.  PI(4,5)P2 bind cofilin and thereby interfere with the interaction 
between actin and cofilin (84). 
The fourth group regulating actin dynamics comprises proteins that crosslink actin 
filaments and the membrane.  These interactions help linking the actin cytoskeleton to the 
plasma membrane by interacting with both actin and membrane proteins, such as integrins 
and receptors, and may help to direct signals to the actin cytoskeleton for remodelling.  The 
crosslinking proteins such as α-actinin, ERM family members and talin have been shown to 
bind and be positively regulated by PI(4,5)P2 (19,53).   
 
1.2.2.2  The regulation of membrane trafficking by PI(4,5)P2 
 
In addition to the important role in actin cytoskeleton dynamics, PI(4,5)P2 signaling plays a 
role in membrane trafficking.  The release of neurotransmitters from neural and 
neuroendocrine cells is mediated by the exocytotic fusion of synaptic vesicles (SVs) and 
dense-core vesicles (DCVs) with the plasma membrane where PI(4,5)P2 regulation is 
suggested to be an important factor (85).  SVs transport non-peptide neurotransmitters such 
as glutamate and DCVs transport peptide neurotransmitters such as dopamine (67).  
Exocytosis is a regulated process including vesicle docking, priming and fusion (53).  
PI(4,5)P2 has been suggested to be important for the ATP-dependent priming phase of 
exocytosis (6,86).  PI(4,5)P2 has been shown to bind to synaptotagmin, CAPS (calcium-
dependent activator protein for secretion) and the MINT-proteins all involved in exocytosis.  
Synaptotagmin is proposed to regulate membrane traffic in neuronal and nonneuronal cells 
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through the docking step which would be regulated by the binding to PI(4,5)P2 (87).  CAPS 
is involved in a triggering step after docking and priming of vesicles (88).   
Furthermore, PI(4,5)P2 is an essential cofactor for clathrin-dependent endocytosis, 
phagocytosis, pinocytosis and endosome motility (67,89-91).  In clathrin mediated 
endocytosis, PI(4,5)P2 is required for the recruitment of adapter proteins such as AP-2 and 
AP180 suggesting that PI(4,5)P2 could be a signal for endocytic localization (24,53,92,93).  
The recruitment of adaptor proteins is required for the invagination of the plasma 
membrane to form a clathrin-coated pit (24).  The initiation of the clathrin-mediated 
endocytosis is suggested to be initiated by the GTPase ARF which is a probable activator of 
PIP5K (94).  The generation of free vesicles from the clathrin-coated pits requires the PH-
containing GTPase dynamin that mainly binds PI(4,5)P2 (67).  The termination of the 
PI(4,5)P2 signaling is suggested to induce the uncoating of the clatrin vesicle (70).  In 
phagocytosis PI(4,5)P2 is required for local changes in actin dynamics that helps in the 
formation of the phagocytic cup (95). 
 
1.2.3            Phospholipase C and inositol polyphosphates signaling 
 
PI(4,5)P2, in addition to functioning as a signaling molecule, can be processed further 
yielding another family of signaling molecules, the inositol polyphosphates (IPP) derived 
from the hydrolysis and phosphorylation by specific lipases and inositol phosphate kinases 
(14,48).  The lipase hydrolysing PI(4,5)P2 is known as phosholipase C (1-
phosphatidylinositol-4,5-bisphophate phosphodiesterase 1) (Figure 3).  Besides differential 
distribution, there are several isoforms of phosphoinositide-specific phospholipase C (PLC) 
such as PLC-β, -γ and -δ in mammalian cells (48,96).  Most PLC isoforms contain a PH 
domain which is suggested to bring the enzyme to its substrate (48).  All PLC hydrolyse 
PI(4,5)P2 to yield inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG).  IP3 is a 
known Ca2+ channel receptor-binding second messenger.  IP3 induces the opening of the 
channels thereby increasing the cytosolic levels of Ca2+ released from intracellular stores 
(97).  DAG is known to activate some isoforms of protein kinase C (PKC), a group of 
kinases involved in many different cellular processes, by binding to the C1 domain 
suggested to induce membrane interaction (98-100).  DAG signaling can be negatively 
regulated by DAG kinases by converting DAG into phosphatidic acid (101).  There is also 
INTRODUCTION 
_________________________________________________________________________ 
_________________________________________________________________________ 
16 
lipid signaling involving PLC function within the nucleus stimulated by growth hormones 
such as PDGF or IGF (48,102).  A possible molecular mechanism is the activation of PKC 
isoforms by DAG and the subsequent phosphorylation of lamins that could induce nuclear 
disassembly (102). 
Besides the role as second messenger, IP3 can be further phosphorylated to yield different 
species of inositol polyphosphates involved in different signaling pathways (12,103). There 
are more than 60 inositol polyphosphates identified so far in different species.  One of the 
first discovered was inositol-1,3,4,5-tetrakisphosphate (IP4) which is produced by the 
phosphorylation of the 3’ position by IP3 3-kinase regulated by calmodulin (104).  There 
are different isoforms of IP3 3-kinase present in different cell types such as neurons, 
endothelial cells where InsP4 is involved in the activation of Ca2+ signaling at the plasma 
membrane but has also been shown to be involved in T lymphocyte development (12,105).  
 
1.2.4  The role of phosphoinositide in diseases 
 
As described previously defects in phosphoinositide regulation, exemplified by the insulin 
signaling pathway, can lead to different diseases.  In addition, phosphoinositide signaling 
can be used for defense against foreign organism or substance but host cell 
phosphoinositide signaling can also be used by pathogens for their own purpose.   
Changes in phosphoinositide levels, specifically PI(4,5)P2, have been observed during 
formation and internalization of the phagocytic cup in the phagocytic cells, macrophages 
(91).  In another type of phagocytic cell, the neutrophil, the phagocyte NADPH oxidase 
involved in ROS is used to kill ingested microbes.  To avoid injury to host tissues the 
assembling of the NADPH oxidase is regulated.  A regulation mechanism is the migration 
of the oxidase to specific membrane compartments which is suggested to be partly 
controlled by PX-phosphoinositide interaction (106).   
Some bacterial pathogens such as Listeria monocytogenes (causes meningitis) and Shigella 
flexneri (causes bacillary dysentery) have evolved to use the phosphoinositide signaling of 
the host for their own purpose to allow invasion through uptake (34,107).  Infection with 
Listeria results in activation of the host PI 3-K which is suggested to induce a 
reorganization of the actin cytoskeleton facilitating uptake of pathogen by phagocytosis 
(108).  Upon Shigella invasion one of the enzymes injected is the invasion plasmid gene D 
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(IpgD) that shows similarity to mammalian phosphoinositide 4-phosphatase and uses the 
host cells PI as substrate (109).  IpgD has been implicated in the decreased cytoskeletal-
membrane adhesion inducing membrane ruffles thereby enhancing bacterial uptake (110).  
A similar mechanism is observed in the bacterial pathogen Salmonella typhimurium where 
a Salmonella orthologue to IpgD, SigD (salmonella invasion gene), is important for host 
invasion (111).  In the fungal pathogen Candida albicans a PIP5K was suggested to be 
involved in the morphogenetic process towards virulence (112). 
 
1.2.5  Phosphoinositide biosynthesis in other organisms 
 
In plants, phosphoinositide signaling is also including various PPI kinase isoforms and 
splice variants. The PPI signaling in plants have mainly been implicated in responses to 
abiotic stress such as drought and cold (48).  In lower eukaryot phosphoinositide 
biosynthesis and signaling is also important as exemplified by PI 3-K signaling in the soil-
living amoeba Dictyostelium discoideum.  PI 3-K in Dictyostelium plays a role in cell 
movement in response to chemoattractant stimulation, chemotaxis.  PI 3-K is suggested to 
control the reorganization of the actin cytoskeleton and redistribution of the subcellular 
localization of signaling components.  Specific PH domain-containing proteins involved in 
chemotaxis bind to PI 3-K products and their localization is PI 3-K-dependent (113).  PI 3-
K signals to Akt that activates PAKa required for myosin II assembly during cytokinesis 
and chemotaxis where PTEN is responsible for the reverse regulation by dephosphorylation 
(113,114).  In addition, there are four inositol 5-phosphatases in Dictyostelium.  Each 
protein shows a distinct composition of domains beside the inositol 5-phosphatase catalytic 
domain suggesting different cellular roles (van Haastert 2003).  In Dictyostelium 
phosphoinositide production has also been found to take place in the nucleus (115).  
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1.3         Phosphoinositide synthesis, turnover and function in 
Saccharomyces cerevisiae 
 
In the model organism Saccharomyces cerevisiae phosphoinositide signaling is important 
involving several kinases and phosphatases (Figure 5)(14,116).  These enzymes show in 
most cases specific kinase or phosphatase activity toward a particular phosphoinositide or 
PI and in addition be regulated by other proteins (14).  There are two branches of 
phosphoinositide production in Saccharomyces cerevisiae with the final product PI(3,5)P2 
or PI(4,5)P2 (Figure 5) (16).  These two branches play a role in the regulation of the actin 
cytoskeleton and in membrane trafficking.  
 
1.3.1   The role of PI(3)P and PI(3,5)P2 signaling in membrane trafficking 
 
In Saccharomyces cerevisiae the phosphatidylinositol 3-kinase VPS34 (vacuolar protein 
sorting) specifically converts PI to PI(3)P important for the carboxypeptidase Y (CPY) 
pathway including transport from trans-Golgi network (TGN), endosomal compartments 
and finally to the vacuole, the equivalent of the mammalian lysosome (117,118).  VPS34 is 
similar to mammalian class III PI 3-K since it can only use PI as substrate (11).  For 
activation, VPS34 is recruited by VPS15 to the Golgi/endosome (43,119,120).  The VPS34-
VPS15 complex also associates with the proteins VPS30 and VPS38 to form a multimeric 
complex, termed complex II (Figure 5) (121).  In addition, VPS34 interacts with two 
proteins, APG6/VPS30 and APG14, that regulate autophagy therefore suggesting a role for 
PI(3)P in cytoplasm to vacuole transport (43). The phosphatidylinositol 3-phosphate 5-
kinase FAB1 (yeast orthologue of mammalian PIKfyve) is non essential and is found on 
vacuolar membranes required for trafficking from the vacuole (122,123).  Maximal 
synthesis of PI(3,5)P2 by FAB1 requires VAC7 and VAC14 (124,125).   
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Figure 5 Model of the synthesis and turnover of the known phosphoinositide species in 
Saccharomyces cerevisiae.  Solid arrow indicates synthesis of phosphoinositide and arrow with dots 
indicates turnover of phosphoinositide.  In the case of PI(4)P it can be produces by three different PI 4-
kinases.  PI(4,5)P2 can be further modified by hydrolysation by phospholipase C (PLC1) to yield DAG and 
IP3.  IP3 can be further phosphorylated to yield inositol poly phosphates.  Modified from. (16). 
 
Loss of FAB1 function results in growth defect, an enlarged and poorly acidified vacuole, 
high temperature sensitivity and has defects in cargo selection for protein sorting within the 
multivesicular body sorting pathway.  These phenotypes are also observed in VAC7 or 
VAC14 deletion mutants (122,124,126).  PI(3,5)P2 is present at low levels under vegetative 
growth but increases significantly upon osmotic stress suggesting a role in this particular 
stress response.  This stress response does not involve the HOG1 (hyperosmotic stress 
response) pathway (127).  For maximal activity during hyper-osmotic shock FAB1 requires 
the presence of VAC7 and VAC14 (128,129).  Mutations in the 5-phosphatase FIG4 were 
reported to suppress the vacuole size defect and temperature sensitivity of vac7 by 
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increased PI(3,5)P2 levels (130).  FIG4 was originally identified in a screen for pheromone-
regulated genes as an induced gene (14).  FIG4 localizes to the vacuole, contains a SAC1 
domain and mediates the turnover of PI(3,5)P2 (Figure 5) (130).   Additional studies 
showed that the FIG4 localization to the yeast vacuole membrane is mediated by the FAB1 
regulator VAC14 (125). 
 
1.3.2 PI(4)P and PI(4,5)P2 signaling and the regulation of the actin 
cytoskeleton and membrane trafficking 
 
In Saccharomyces cerevisiae three PI 4-kinases exists: PIK1, STT4, and the newly 
identified LSB6 (Figure 5) (14,131).  Deletion of one kinase cannot be rescued by increased 
expression of the other suggesting different functions for each kinase (132). 
The PI 4-kinase PIK1, is essential and involved in mating-pheromone signaling cascade, 
protein exocytosis, structure of the Golgi and cytoskeletal function {Garcia-Bustos, 1994 
#150;Audhya, 2000 #14;Walch-Solimena, 1999 #145;Flanagan, 1993 #389}.  PIK1 
localizes to the Golgi and to the nucleus but the role of nuclear localization remains unclear 
(133,134). The activity and the localization of PIK1 is regulated by the small Ca2+-binding 
protein frequenin (FRQ1), the yeast orthologue of mammalian frequenin involved in vesicle 
mediated neurotransmitter release (135,136).  
The PI 4-kinase STT4 (Figure 5) (staurosporine- and temperature-sensitive), is essential, 
localizes to the plasma membrane and is involved the organization of the actin 
cytoskeleton, cell wall integrity and normal vacuolar morphology (120,132,137,138). 
PI(4)P produced by STT4 is used both as a substrate by MSS4 to yield PI(4,5)P2 and is also 
an essential component involved in the transport of the essential aminophospholipid 
phosphatidylserine from the ER to the Golgi (132,139). The transmembrane protein SFK1 
is required for the correct localization of STT4 to the plasma membrane (132).  SAC1 is the 
phosphatase responsible for the dephosphorylation of STT4 derived PI(4)P.  A mutation in 
the 4-phosphatase SAC1 was originally isolated as a recessive suppressor of actin 
mutations.  This suppression was suggested to be mediated by a STT4-dependent PI(4)P 
signaling to the actin cytoskeleton (140,141).  SAC1 has also been postulated to act on a 
pool of PI(4)P in the yeast Golgi but the role of this turnover remains unclear (Figure 5) 
(14,141).  Furthermore, SAC1 has been localized to the ER depending on the C-terminal 
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transmembrane domain and shown to be important for vacuolar morphology (141).  Some 
groups have observed dephosphorylation of PI(3)P by SAC1 but the biological role is 
unknown (125,142).  SAC1 exhibits in vitro phosphatase activity towards all 
monophosphorylated PIs but in vivo SAC1 is only able to use PI(4)P as substrate due to its 
localization to the ER (141).  STT4 is localized to the plasma membrane and it is possible 
that the STT4-generated PI(4)P is transported to the SAC1-containing membranes with via 
an unknown mechanism (141).  Mutations in SAC1 lead to different phenotypes such as 
inositol auxotrophy and ATP transport deficiencies.  A sac1 mutant is also reported to 
suppress the lethality of SEC14-deficiency.  SEC14 is responsible for establishing a critical 
phospholipid composition in Golgi membranes (143).  A sac1 mutant shows synthetic 
interaction with mpk1 mutants, a cell wall integrity pathway component.  The growth defect 
correlates with abnormal levels of the chitin synthase CHS2 caused by defective trafficking 
(144).  Deletion of SAC1 also causes the chitin synthase CHS3 to be erroneously 
transported to the vacuole instead of to the cell periphery (107,145). 
PI(4)P synthesized by STT4 is used further by the only phosphatidyl 4-phosphate 5-kinase 
in Saccharomyces cerevisiae, MSS4 to produce PI(4,5)P2.  MSS4 was originally found as a 
multicopy suppressor of STT4 mutation and similar to STT4, MSS4 localizes to the plasma 
membrane (14,53,146,147).  (Figure 5). MSS4 shows 40-44% identity to human PIP5K 
(11).  In addition, conditional mss4 mutant is functionally replaced by the murine type I β 
PI 4-P 5-kinase and the kinase activity is enhanced in the presence of phosphatidic acid 
which is characteristic of mammalian PIP5K (146,148).  MSS4 is essential and required for 
the proper organization of the actin cytoskeleton and endocytosis (146,147).  MSS4 has 
also been suggested to play a role in prospore formation being upstream of the 
phospholipase D (PLD), SPO14.  SPO14-mediated PtdOH production is in accordance to 
PI(4,5)P2 as cofactor of PLD in mammalian cells (149,150).  In addition, an MSS4 mutant 
was found to rescue the growth defect of CSG2 (involved in sphingolipid synthesis) mutant 
induced by the presence of Ca2+.  In the same experiment TOR2 and AVO3 mutants, 
components of the TORC2 signaling pathway involved in the organization of the actin 
cytoskeleton, were also found among the suppressors.  The link between MSS4, TORC2 
and sphingolipid synthesis remains unclear (151). 
Levels of PI(4,5)P2 seems to be stable under vegetative growth but increases upon heat 
shock suggesting a regulation mechanism (147).  MSS4 localization to the plasma 
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membrane is regulated by casein kinase I phosphorylation.  The same study shows that 
MSS4 has a functional bipartite NLS.  Overexpression of MSS4 leads to its partial 
localization to the nucleus suggesting a possible mechanism of regulation (152).  However 
these two regulation mechanisms have not been linked to the role of MSS4 in the 
organization of the actin cytoskeleton. 
Turnover of PI(4,5)P2 in Saccharomyces cerevisiae is controlled by INP51, INP52, INP53 
(Figure 5) that belongs to the phosphoinositide 5-phosphatase family (14,116).  In contrast, 
INP51, INP52 and INP53 belong to the synaptojanin-like family that are highly conserved 
phosphoinositide 5-phosphatases defined by three domains: a Sac1-like domain exhibiting 
in most cases phosphoinositide phosphatase activity, a central PI(4,5)P2 5-phosphatase 
domain, and a C-terminal proline-rich domain (14).  Cells lacking both INP51 and INP52 
(inp51 inp52) exhibits thickened cell wall, endocytosis defects, actin cytoskeletal 
disorganization and fragmented vacuolar structures (153,154).  inp51 inp53 double deletion 
mutant show synthetic interaction but not as severe as inp51 inp52 (14).  Interestingly, 
inp53 deletion mutant, but not inp52, show compensatory mechanisms upon loss of SAC1 
phoshatase activity (141).  The triple INP51/INP52/INP53 deletion mutant is not viable 
(154).  INP52 and INP53 via the Sac1 domain interacts with the protein BSP1, which is 
suggested to be linked to the cortical actin cytoskeleton (155).  Furthermore, INP53 has 
been implicated in the process of Golgi to endosomal trafficking and may localize to the 
Golgi (14).  All these phenotypes indicate that INP51, INP52 and INP53 have overlapping 
functions as well as unique functions.  INP52 and INP53 have the capacity to 
dephosphorylate all four phoshpoinositides observed in yeast in contrast to INP51 that only 
dephosphorylate PI(4,5)P2 (14,125); (156).  INP51 differs from INP52 and INP53 in that 
the Sac1-like domain lacks phosphatase activity which could explain the specific PI(4,5)P2 
5-phosphatase activity (157).  INP51 deletion mutant confers synthetic interaction with a 
pan1 conditional mutant defective in endocytosis (158).  PAN1 is the yeast orthologue of 
mammalian EPS15 (involved in clathrin-coated vesicle formation) known to interact with 
the mammalian orthologue of yeast INP family, synaptojanin 1 (see 1.3.2).  The phenotypes 
of inp51 mutant suggest that it has overlapping functions with INP52 and INP53 but that it 
has unique functions as well.  It is suggested to be involved in endocytosis and regulation 
of the actin cytoskeleton during vegetative growth (14).  It was observed that in some 
genetic backgrounds the inp51 mutant shows cold resistance and simultaneous deletion of 
INTRODUCTION 
_________________________________________________________________________ 
_________________________________________________________________________ 
23 
PLC1 does not affect this tolerance.  This indicates that PLC1 mediated hydrolysis of 
PI(4,5)P2 is not required for INP51 signaling (156). 
 
1.3.3            PI(4,5)P2 targets in Saccharomyces cerevisiae 
 
In Saccharomyces cerevisiae there are more than 20 proteins with known and unknown 
function that contains a putative PH domain that possibly can bind PI(4,5)P2.  The PH-
containing proteins are implicated in different processes and localization differs widely 
suggesting that the function of PH domain is complex.  There are also cellular processes 
affected by PI(4,5)P2 biosynthesis but the targets are not known.  PI(4,5)P2 synthesis and 
turnover has been suggested to be important in vacuole dynamics such as the process of 
priming and docking important for vacuole association but the mechanism and targets 
remain unknown (23).  There are several actin cytoskeleton regulating proteins that bind 
PI(4,5)P2 but do not contain a specific domain such as profilin and twinfilin (159,160).  
Profilin localizes to the plasma membrane through electrostatic interactions with PI(4,5)P2 
and not via a PH domain (18,159).  PI(4,5)P2 could regulate actin polymerization via 
profilin indicated by the synthetic interaction observed in an mss4 / pfy1 double mutant 
(146).  The phosphoinositide-binding proteins BOI1 and BOI2 are implicated in bud 
growth linked to RHO3 GTPase signaling (161,162).  The RHO1-GEF ROM2 binds 
PI(4,5)P2 through its PH domain which regulates its localization.  PH domains are not only 
found in GEFs but also in GAPs such as BEM2 or BEM3 that also contains a PX domain.  
The binding to PPI has not been characterized (163). 
There are other domains than PH domains that can bind PI(4,5)P2 which is the case for 
ENTH domain.  The mammalian epsin orthologue proteins in yeast, ENT1 and ENT2, 
contain an ENTH domain and might act as adaptors to recruit the machinery for actin 
polymerization and internalization of ubiquitinated receptor (164,165).  SLA2, linked to 
RSP5 (ubiquitin-protein ligase) signaling, is another ENTH-containing protein involved in 
both endocytosis and the organization of the actin cytoskeleton (166).   
There are several proteins that harbour a PH domain but do not localize to the plasma 
membrane to where PI(4,5)P2 synthesis seems to be restricted (146,167,168).  The 
oxysterol-binding proteins are examples of PH domain containing proteins that localize to 
the Golgi and are suggested to bind PI(4,5)P2 (169,170). 
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1.3.4  Phospholipase C and inositol polyphosphate signaling 
 
PLC1 (Figure 5) is the only phosphoinositide-specific phospholipase in Saccharomyces 
cerevisiae (171). ISC1 is another phospholipase C in Saccharomyces cerevisiae, but its 
substrate is inositol phosphosphingolipid (172).  PLC1, most similar to mammalian PLC-δ 
isoforms, hydrolyzes PI(4,5)P2 to yield diacylglycerol (DAG) and inositol 1,4,5-phosphate 
(IP3) (48).  PLC1 is important for cell growth since the loss of PLC1 function results in 
slow growth or is lethal depending on the genetic background of strains (173).  Mutations 
in PLC1 lead to many different phenotypes.  It has been suggested to be required for a 
number of nutritional and stress-related responses such as glucose metabolism and 
oxidative stress (171,174-177).  PLC1 has been suggested to be involved in nitrogen 
signaling pathway by interacting with GPR1 a hormone receptor-like plasma membrane 
protein (178).  Furthermore, overexpression of PLC1 is able to suppress defects in the 
TORC1 and TORC2 signaling pathway involving temporal control of cell growth and 
organization of the actin cytoskeleton respectively (Figure 7) (179).  It is not clear how the 
products of PLC1, IP3 and DAG are linked to these two signaling pathways.  IP3 has been 
shown to be involved in raising Ca2+ levels in the cell but the IP3 target remains unknown 
(177).  In Saccharomyces cerevisiae there is no known target for DAG but it has been 
suggested to be the protein kinase C, PKC1, involved in the organization of the actin 
cytoskeleton (180).  PKC1, a component of the cell wall integrity pathway and the TORC2 
signaling pathway, has a putative DAG binding domain (179,181-183).   
The IP3 produced by PLC1 can be further phosphorylated by different kinases to yield 
inositol polyphosphates (184).  Inositol phosphate kinase 2 (IPK2) and inositol phosphate 
kinase 1 (IPK1) convert IP3 to inositol-1,3,4,5,6-pentakisphosphate (IP5) and  inositol-
1,3,4,5,6-hexakisphosphate (IP6) respectively (185,186).  Inositol polyphosphates have 
been implicated in nuclear signaling (102).  In Saccharomyces cerevisiae ARG82/IPK2, an 
inositol phosphate kinase, is needed for efficient recruitment and regulation of chromatin 
remodelling complexes to the PHO5 promoter where PHO5 is involved in phosphate 
metabolism (17).  Another inositol phosphate kinase, KCS1, can further pyrophosphorylate 
some of the IP6 to yield bisphosphoinositol-IP5 (PP-IP5) which has been implicated in 
biogenesis of the vacuole and response to environmental stress (187,188).  
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1.4 The cell wall integrity pathway and the TOR complex 2 
signaling pathway  
 
Different signaling pathways in Saccharomyces cerevisiae regulate cell growth such as by 
nutrient availability sensing by the TORC1 signaling pathway. Growth is oriented by a 
polarized actin cytoskeleton that directs secretory vesicles to the growth site (189).  The 
actin cytoskeleton is important for the transport of cell wall components.  The cell wall is a 
complex network of molecules and proteins that surrounds the entire cell.  Furthermore it is 
important for the rigidity of the cell preserving the osmotic integrity (190).  Remodeling of 
the cell wall is important during vegetative growth and during pheromone-induced 
morphogenesis (191).  In addition, the yeast cell wall is important for cell survival in a 
fluctuating environment (192).  
 
1.4.1  The actin cytoskeleton 
 
The actin cytoskeleton of Saccharomyces cerevisiae is built up of cables and patches.  
Cables are filamentous actin that organizes in parallel towards the incipient and growing 
bud.  Actin patches consist of actin and actin-binding proteins that localize to the incipient 
and growing bud.  Both cables and patches change their arrangement in a cell cycle-
dependent manner (193).  There are many actin-binding proteins which are conserved from 
yeast to mammals such as twinfilin and profilin that are regulated by PPI (see 1.3.3.1) 
(159,194).  The actin cytoskeleton is important for the cell shape, is highly dynamic in 
response to changes in the external environment and implicated in different cellular 
processes such as endocytosis (76,195,196). 
 
1.4.2 The cell wall 
 
The cell wall is composed of an outer layer of glucan (60%), mannoproteins (40%) and a 
small amount of chitin (1%).  Glucan, produced by FKS1 an FKS2, gives rigidity to the cell 
and the synthesis is cell-cycle dependent.  The mannoproteins (cell wall proteins) are found 
on the outside of the cell wall and are linked via β1,6-glucan to the underlying β1,3-glucan 
(190).  Chitin (polymer of N-acetylglucosamine) synthesis is cell-cycle dependent and is 
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deposited (below glucan) to specific locations of the cell such as a ring at the neck of the 
emerging and growing bud (144,197).  Chitin synthesis involves three enzymes: CHS1, 
CHS2 and CHS3 that are tightly regulated (190,198).  CHS1 is involved in cell wall repair 
(197).  CHS2 is required for the formation of the chitin disk that closes the primary septum 
at cytokinesis (199).  The function of CHS3 is to produce the chitin ring that appears at the 
basis of an emerging bud and of the small amount of chitin interdispersed in the cell wall 
and is therefore the major chitin producing synthase (90% of total chitin) (197).  The 
regulation of chitin synthesis is complex including transcriptional and posttranslational 
control (191,200).  Transcription seems to be regulated at different stages of the cell cycle.  
CHS3 is posttranslationally modified and regulated by different mechanisms: its 
localization/transport is regulated by the actin cytoskeleton and endocytosis, polarity 
establishment proteins, PKC1 pathway and specific chitin synthase proteins such as CHS5 
and CHS7 (197,199-201).  Upon (genetic) disturbance of the glucan composition of the cell 
wall it is postulated that a compensatory mechanism is activated by increased chitin 
production indicating tightly controlled cell wall structure (192).   
 
1.4.3  The cell wall integrity pathway 
 
Response to cell wall damage to prevent the cell from cell lysis includes four mechanisms: 
changes in the level of cell wall components such as chitin, the association between the cell 
wall components, a transient redistribution of cell wall synthesis and a transient 
depolarization of the actin cytoskeleton probably redirecting the cell wall machinery 
(197,202).  Normally, cell wall synthesis occurs at the active growth site but upon damage 
cell wall synthesis redistributes to the whole cell periphery (195,203).  The cell wall 
integrity pathway has been suggested to sense and activated by cell wall damage induced 
by heat or Cell wall disturbance upon heat or hypotonic shock.  Activation of the cell wall 
integrity pathway induces the expression of genes important for the cell wall synthesis or 
assembly to repair cell wall damage (192).  
Cell wall stress is monitored by transmembrane proteins including members of the WSC 
family and the MID2 protein (195,202).  Cell wall damage probably induces membrane 
stretch that is sensed by these integral membrane proteins (204-206).  Similar to 
mammalian cells, RHO GTPases in Saccharomyces cerevisiae are important for the 
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organization of the actin cytoskeleton (207).  In Saccharomyces cerevisiae the RHO 
GTPases RHO1 (Figure 6) and possibly RHO2 control polarization of the actin 
cytoskeleton and cell wall synthesis thereby mediating bud growth and regenerating the cell 
wall upon damage (197,208,209).  RHO1 activity is regulated by a set of proteins: 
GDP/GTP exchange factors (GEFs), GTPase-activating proteins (GAPs) and guanine 
nucleotide dissociation inhibitors (GDIs).  WSC1 transduce response to cell wall damage 
by activating RHO1 via the GEF ROM2 by an unknown mechanism (195,204).  ROM1 and 
TUS1, homologous to ROM2, are also involved in the activation of RHO1 (210,211).  The 
GAP SAC7, an important negative regulator of RHO1 and negative regulator of the cell 
wall integrity pathway, transforms RHO1 into an inactive GDP-bound form by increasing 
RHO1’s low intrinsic GTPase activity.  BEM2, BAG7 and LRG1 are also RHO1 GAPs 
regulating different RHO1 functions (163,212,213).  BEM2 and SAC7 negatively control 
the actin cytoskeleton through the PKC1 pathway.  In addition, SAC7 and BAG7 also 
negatively control the actin cytoskeleton by an unknown effector pathway.  LRG1 
negatively regulates the RHO1-dependent activation of FKS1 but does not regulate the 
PKC1-MAP kinase cascade (212). 
The existence of different functions of the GAPs probably ensures regulation of the effector 
pathways at the appropriate place and time (163).  It is not clear how the GAPs achieve 
their specificity but differential localization and regulation is a possible mechanism which 
is exemplified by BEM2 that contains a PH domain (163). 
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Figure 6 The cell wall integrity pathway  
Environmental stimuli that affect cell wall is sensed by WSC1 that activates the effectors of the cell wall 
integrity pathway.  This induces reorganization of the actin cytoskeleton and changes in transcription of genes 
involved in the remodelling of cell wall. 
 
RHO1 has five downstream effectors (163).  RHO1 is part of the β 1,3-glucan synthase 
complex comprising FKS1 or FKS2 (depending on environmental conditions) which is 
stimulated in a GTP-dependent manner (190,214).  RHO1 regulates the glucan synthase 
complex through the localization and activity of FKS1 and FKS2 (195,208).  In addition, 
RHO1 also interacts with a formin-family member BNI1, with the stress responsive 
transcription factor SKN7 and with SEC3 involved in polarized exocytosis (215-218).  The 
fifth effector is PKC1, component of the cell wall integrity pathway, is activated by RHO1 
leading in turn to the activation of a MAP (mitogen activated) kinase cascade.  This MAP 
kinase cascade consisting of BCK1, MKK1/2 and MPK1 (Figure 6) (181,195,219,220).  
PKC1 is activated upon cell wall stress such as heat shock, to control the organization of 
the actin cytoskeleton and transcription of genes encoding cell wall biosynthetic enzymes 
(179,221,222).  RHO1 and PKC1 are needed both for depolarization and repolarization of 
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the actin cytoskeleton (195).  It has been shown that PKC1 is activated by 
phosphatidylserine in vitro that is characteristic for the atypical ζ isoform of protein kinase 
C in mammalian cells.  It has been suggested that PKC1 interacts with lipids 
(diacylglycerol) via its C1 and/or C2 domain but the physiological role remains unclear 
(220,223).   
The MAP kinase MPK1, downstream of PKC1, is activated by dual phosphorylation of its 
two conserved theronine (Thr190) and tyrosine (Tyr192) residues (224).    The activation of 
MPK1 induces the transcription of genes involved in the cell wall biosynthesis such as 
CHS3 and integral cell wall proteins such as GPI proteins (191).  The main transcription 
factor involved in the MPK1 signaling is RLM1 but other transcription factor might also be 
involved such as NHP6A and NHP6B and SBF (225-227).  MPK1 interacts with RLM1 
possibly for activation by phosphorylation (228,229).  However, loss of MPK1 function 
leads to more severe phenotypic defects than a rlm1 deletion mutant suggesting that MPK1 
have additional effectors (191).  
 
1.4.4  The TOR signaling pathways 
 
In Saccharomyces cerevisiae, the target of rapamycin proteins, TOR1 and TOR2, play an 
important role in the regulation of cell growth (Figure 7) and have strong similarity to the 
catalytic domains of PI 3-K and PI 4-K (11,230).  This catalytic domain, named PIK 
(phosphatidylinositol kinase) domain, is present in various kinases, in addition to the TOR 
proteins, for example mammalian ATM (ataxia telangiectasia mutated) and the yeast MEC1 
both involved in DNA damage response (230,231).  However, it remains unclear if the 
PIK-domain has lipid kinase activity (230).  
The TOR proteins in Saccharomyces cerevisiae are part of two distinct complexes: TOR 
complex 1 (TORC1) and TOR complex 2 (TORC2).  TORC1, contains TOR2 or TOR1, 
and associated partners, is essential for temporal control of cell growth and controls 
transcription and translation in response to nutrients. TORC2 contains TOR2, but not 
TOR1, and associated partners AVO1, AVO2, AVO3 and LST8 and is essential for spatial 
control of cell growth through the regulation of the organization of the actin cytoskeleton 
(Figure 7) (232).  TORC2 signals to the GEF ROM2 by an unknown mechanism activating 
a RHO1-dependent effector branch, the MAP kinase cascade, regulating the organization of 
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the actin cytoskeleton but not the cell wall synthesis (179,209,232).  TOR proteins are 
phosphatidylinositol kinase-related kinase, as mentioned above, but so far it has not been 
shown to have lipid kinase activity.  However, lipid signaling might be important in the 
TOR2 signaling cascade since it was observed that overexpression of MSS4 or PLC1 the 
growth defect of a tor2 conditional mutant defective in the organization of the actin 
cytoskeleton (179).  These results suggest that phosphoinositide signaling could have an 
important role in the TOR2 signaling pathway (179).  ROM2 contains a PH domain which 
binds PI(4,5)P2 (132,209).  The localization of ROM2 changes in a mss4 conditional mutant 
under non-permisssive conditions suggesting that PI(4,5)P2 signaling is important for 
correct localization of ROM2 (132).  In addition, overexpression of ROM2 lacking the PH 
domain is not longer able to suppress the growth defects of a tor2 mutant.  This suggests 
that the GEF ROM2 might be the link between MSS4 signaling and the TORC2 signaling 
pathway (209).   
TORC1 TORC2
TAP42
transcriptiontranslation
ROM2
RHO1GTP
PKC1
MAP kinase cascade
Actin cytoskeleton organization
Nutrients
rapamycin
?
SAC7
RHO1GDP
Plasma membrane
 
Figure 7 The TOR signaling pathways 
TORC1 comprises either TOR1 or TOR2 and is important for temporal control of cell growth in response to 
nutrients regulating transcription and translation.  TORC1 signaling can be inhibited by rapamycin.  TORC2 
only comprises TOR2, signals through the PKC1 pathway and is important for the organization of the actin 
cytoskeleton. 
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Aim of the thesis 
 
 
The family of phosphoinositides, conserved from yeast to mammals, is a complex group of 
signaling molecules.  The importance of phosphoinositide signaling is based on their 
implications in several human diseases. 
The aim of this thesis is to understand how the essential phosphoinositide 
phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P2), is regulated in the model organism 
Saccharomyces cerevisiae.  We specifically focus on PI(4,5)P2 signaling linked to the 
TORC2 signaling pathway and the cell wall integrity pathway studying the role of PI(4,5)P2 
5-phosphatases INP51, INP52 and INP53 and how they are regulated.
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ABSTRACT 
PPI regulate a wide range of cellular processes, including proliferation, survival, 
cytoskeleton remodelling and membrane trafficking, yet the mechanisms controlling the 
kinases, phosphatases and lipases that modulate phosphoinositide levels are poorly 
understood.  In the present study, we describe a mechanism controlling MSS4, the sole 
phosphatidylinositol (4)-phosphate 5-kinase in Saccharomyces cerevisiae.  Mutations in 
MSS4 and CMD1, encoding the small Ca2+-binding protein calmodulin, confer similar 
phenotypes, including loss of viability and defects in endocytosis and in organization of the 
actin cytoskeleton.  Overexpression of MSS4 suppresses the growth and actin defects of 
cmd1-226, a temperature-sensitive calmodulin mutant which is defective in the organization 
of the actin cytoskeleton.  Finally, the cmd1-226 mutant exhibits reduced levels of 
phosphatidylinositol (4,5)-bisphosphate.  These findings suggest that calmodulin positively 
controls MSS4 activity and thereby the actin cytoskeleton. 
 
Key words: CMD1, MSS4, PtdIns(4)P 5-kinase, PtdIns(4,5)P2, Saccharomyces cerevisiae. 
Abbreviations used: ARF, ADP-ribosylation factor; MAPK, mitogen-activated protein 
kinase; PKC, protein kinase C; PLC, phospholipase C; SD, yeast nitrogen base/ammonium 
sulphate/dextrose media; TRITC, tetramethylrhodamine β-isothiocyanate; ts, temperature-
sensitive; YPD, yeast extract/peptone/dextrose media. 
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INTRODUCTION 
Phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P2] plays a role in a remarkable number 
of cellular processes.  PtdIns(4,5)P2 is cleaved by phospholipase C (PLC) to generate the 
second messengers diacylglycerol and Ins(1,4,5)P3 that activate protein kinase C (PKC) 
and increase intracellular Ca2+ respectively (233).  Uncleaved PtdIns(4,5)P2 directly binds 
and regulates several target proteins (for review see (6)).  For example, PtdIns(4,5)P2 (i) 
binds pleckstrin homology domains present in a variety of proteins involved in signal 
transduction  (25,234,235); (ii) binds actin-binding proteins and thereby regulates 
organization of the actin cytoskeleton   (6); (iii) regulates the small GTPase ADP-
ribosylation factor (ARF) by recruiting both the guanine nucleotide exchange factor and the 
GTPase-activating protein for ARF ((236-238), but see  (239)); and (iv) binds several 
proteins involved in the formation of  clathrin-coated vesicles during endocytosis  (240-
242). 
In mammalian cells, PtdIns(4,5)P2 is synthesized via two independent reactions.  It is the 
product of PtdIns(4)P 5-kinases, which phosphorylate PtdIns4P at the D-5 position of the 
inositol ring.  It is also produced by phosphorylation of PtdIns5P at the D-4 position of the 
inositol ring by PtdIns(5)P 4-kinases  (52).  Little is known about the regulation of 
PtdIns(4,5)P2 synthesis.  The activation of PtdIns(4)P 5-kinases by phosphatidic acid, a 
product of phospholipase D, is well documented  13 (148,243,244), but two recent studies  
(245,246) demonstrate that PtdIns(4)P 5-kinases are also activated by ARF to control 
membrane ruffling and structural integrity of the Golgi complex.  The investigation of the 
physiological function of PtdIns(4,5)P2 and the mechanisms regulating its synthesis in 
mammalian cells is complicated not only due to the existence of both PtdIns(4)P 5-kinases 
and PtdIns(5)P 4-kinases, but also because of the presence of different isoforms of these 
kinases.  In the yeast Saccharomyces cerevisiae, PtdIns(4,5)P2 is produced solely via 
MSS4-mediated phosphorylation of PtdIns4P  (147).  MSS4 is encoded by the essential 
gene MSS4 which when mutated causes disorganization of the actin cytoskeleton, aberrant 
cell morphology and loss of cell integrity (146,147). 
Calmodulin is a Ca2+-binding protein also implicated in the regulation of many proteins, 
including metabolic enzymes, protein kinases, a protein phosphatase, transcription factors, 
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ions transporters, receptors, motor proteins and cytoskeletal components (for reviews see  
(247,248)).  Studies using temperature-sensitive (ts) calmodulin mutations (cmd1ts) in S. 
cerevisiae have demonstrated that calmodulin is an essential protein required for 
organization of the actin cytoskeleton, endocytosis, nuclear division and bud emergence 
(249,250).  Interaction of calmodulin with some target proteins has been reported 
(251,252); however, the exact mechanisms by which calmodulin controls these cellular 
processes is largely unknown.  Our findings reveal a new mode of calmodulin action which 
operates via regulation of PtdIns(4,5)P2 synthesis. 
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EXPERIMENTAL 
Strains, plasmids and media 
The S. cerevisiae strains used in this study are listed in Table 1.  All strains were isogenic 
derivatives of JK9-3d.  Plasmids used in this work are listed in Table 2.  Rich media, YPD 
[1% (w/v) yeast extract, 2% (w/v) peptone and 2% (w/v) dextrose], and synthetic defined 
minimal media, SD [0.17% (w/v) yeast nitrogen base, 0.5% (w/v) ammonium sulphate and 
2% (w/v) dextrose], supplemented with the appropriate nutrients for plasmid maintenance 
were as described previously  (253). 
Table 1 Yeast strains 
Strain Genotype 
JK9-3da MATa leu2-3,112 ura3-52 trp1 his4 rme1 HMLa 
JK9-3dα MATα leu2-3,112 ura3-52 trp1 his4 rme1 HMLa 
TB50a JK9-3da his3 HIS4 
SD18-1d TB50a mss4::HIS3MX6/Ycplac111::MSS4 
SD19-3a TB50a mss4::HIS3MX6/Ycplac111::mss4-2ts 
SD54-11d SD18-1d bar1::kanMX4 
SD55-1b SD19-3a bar1::kanMX4 
TS45-1a TB50a mpk1::TRP1 
SH121 JK9-3da ade2 tor2::ADE2-3/Ycplac111::tor2-21ts 
SH27-1b JK9-3dα ade2 mpk1::TRP1 tor2::ADE2-3/Ycplac111::tor2-21ts 
DBY7462 MATa leu2-3,112 ura3-52 trp1 his3 lys2 
DBY7446 DBY7462 cmd1-226 
DBY7445 DBY7462 cmd1-228 
DBY7449 DBY7462 cmd1-239 
Table 2 Plasmids 
Plasmid Description 
pROM2 pAS30, ROM2 (2µ, URA3)  (209) 
pRHO2 pC-186, RHO2 (2µ, URA3)  (254) 
pCMD1 pSD14, CMD1 in YEplac195 (2µ, URA3) 
pBCK1-20 BCK1-20 in pRS352 (CEN, URA3)  (183) 
pMKK1 MKK1 in YEp352 (2µ, URA3)  (183) 
pMPK1 MPK1 in YEp352 (2µ, URA3)  (183) 
pMSS4 pSH22, MSS4 in pSEY18 (2µ, URA3)  (179)
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pPKC1 pSH24, PKC1 in pSEY18 (2µ, URA3)  (179)
Determination of cellular phosphatidylinositol levels 
Cells were grown at 24°C in the presence of 50µCi/ml [3H]inositol (Amersham 
International, Little Chalfont, Bucks., U.K.) to a D600 of 0.7 (D is attenuance), harvested by 
centrifugation, and resuspended in one-fifth the original volume.  After control samples had 
been removed, cells were incubated at 37°C and aliquots (200µl) were collected at different 
times.  Cells were arrested by the addition of 2.5 vols.  of methanol, and disrupted by 
vortexing for 5min with glass beads.  Lipids were extracted and analysed as described 
previously  (255).  The radioactivity associated with each phospholipid was quantified and 
corrected to the level of total phosphatidylinositol found in the control samples. 
Endocytosis assays 
Lucifer Yellow (Fluka, Buchs, Switzerland) accumulation in vacuoles was assayed as 
described previously  (256).  Cells were grown in YPD at 24°C to mid-log phase, shifted to 
37°C and incubated for 1h in the presence of 4mg/ml Lucifer Yellow.  Cells were then 
washed three times in 1ml of ice-cold buffer (50mM sodium phosphate, 20mM sodium 
azide and 20mM sodium fluoride, pH7.0).  [35S]α-Factor-uptake assays were performed 
using the continuous-presence protocol as described previously  (256).  Cells were grown in 
YPD at 24°C to exponential phase, and the α-factor-uptake assay was carried out at 24°C or 
37°C.  Cells assayed at the restrictive temperature (37°C) were preincubated at this 
temperature for 15min. 
Rhodamine–phalloidin staining of actin 
Cells were grown to early logarithmic phase, fixed in formaldehyde, and stained with 
phalloidin–tetramethylrhodamine β-isothiocyanate (TRITC) conjugate (Sigma) to visualize 
actin as described previously  (257). 
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RESULTS 
Calmodulin and MSS4 are functionally related 
We have shown previously that the yeast PtdIns(4)P 5-kinase MSS4 is an essential protein 
required for proper organization of the actin cytoskeleton  (147).  The actin cytoskeleton 
plays a fundamental role in endocytic uptake in yeast  (258) and recent studies  (259,260) in 
mammalian cells suggest a role for PtdIns(4,5)P2 in receptor-mediated endocytosis.  To 
investigate further the role of PtdIns(4,5)P2 in endocytosis, we examined fluid-phase and 
receptor-mediated endocytosis in a temperature-sensitive (ts) mss4 mutant.  mss4ts cells 
shifted to non-permissive temperature (37°C) were defective in fluid-phase endocytosis, as 
evidenced by a lack of vacuolar accumulation of the dye Lucifer Yellow, and in receptor-
mediated uptake, as evidenced by a reduction in internalization of the α-factor pheromone ( 
Figure 1).  These results suggest that PtdIns(4,5)P2 is required for the internalization step of 
endocytosis. 
The above finding revealed that the phenotype of a mss4ts mutant is remarkably similar to 
that of a cmd1 mutant defective in the Ca2+-binding protein calmodulin.  Calmodulin, like 
MSS4, is an essential protein required for proper organization of the actin cytoskeleton 
(249) and for the internalization step of endocytosis (250,251).  Furthermore, like a mss4ts 
mutant, the temperature-sensitive cmd1-226 mutant loses viability after prolonged 
incubation at restrictive temperature; approx. 30% of cmd1-226 cells and 80% of mss4ts 
cells were non-viable after 4h at 37°C, as evidenced by staining with the vital dye 
Methylene Blue.  No loss of viability was detected with a similarly treated wild-type strain.  
The growth defect of both the mss4ts and cmd1-226 mutants was at least partly suppressed 
by osmotic stabilization of the cells, i.e. by the addition of 1M sorbitol to the growth 
medium (results not shown), indicating that both mutants are impaired in cell integrity.  
Finally, both mss4 (146) and cmd1-226 ( Figure 2) mutants display aberrant morphology at 
37°C.  Altogether, these findings suggest that MSS4 and calmodulin have related functions. 
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Figure 1 MSS4 is required for the internalization step of endocytosis 
Wild-type (WT; MSS4; SD54-11d) and mss4ts (SD55-1b) cells were assayed for Lucifer Yellow 
accumulation in the vacuole at 37°C (upper panel) or α-factor uptake at 24°C and 37°C (lower 
panel).  For the Lucifer Yellow uptake, the same field of cells is viewed by fluorescence (right-hand 
panels) and Nomarski (left-hand panels) microscopy.  The results shown for α-factor uptake 
represent the mean of two independent experiments±S.E.M. 
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Figure 2 Multicopy MSS4 suppresses a cmd1 mutation 
Logarithmic cultures of cmd1-226 (DBY7446) cells carrying an empty vector (cmd1-226), pCMD1 
(CMD1) or pMSS4 (cmd1-226+pMSS4) were grown at 24°C, shifted to 37°C for 4h, fixed, stained 
with TRITC–phalloidin, and observed by Nomarski (lower panel) and fluorescence (actin staining; 
upper panel) microscopy.  Arrowheads indicate the abnormally-shaped, medium-sized buds of 
cmd1-226 cells. 
 
To investigate further whether calmodulin and MSS4 are functionally related, we examined 
whether CMD1 and MSS4 interact genetically.  Temperature-sensitive CMD1 mutations fall 
into different intragenic complementation groups, indicating a role for calmodulin in 
different, essential cellular processes  (249,261).  Representative mutations from the 
different complementation groups were examined for suppression by a multicopy MSS4 
gene.  Overexpression of MSS4 restored growth ( Figure 3) in a cmd1 mutant defective in 
organization of the actin cytoskeleton (cmd1-226), but did not restore growth of mutants 
defective in calmodulin localization (cmd1-228) or in nuclear division (cmd1-239) (results 
not shown).  The suppression of the cmd1-226 growth defect by overexpression of MSS4 
suggested that MSS4 can restore proper organization of the actin cytoskeleton in cmd1-226 
cells.  To test this, the actin cytoskeleton was visualized in cmd1-226 mutant cells 
Calmodulin activates Ptdlns(4,5)P2 synthesis 
_________________________________________________________________________ 
_________________________________________________________________________ 
40 
overexpressing MSS4 ( Figure 2).  Cells were grown at permissive temperature (24°C) and 
then shifted to restrictive temperature (37°C) for 4h.  cmd1-226 cells exhibited a severe 
defect in the organization of the actin cytoskeleton; actin cables were undetectable and 
cortical actin patches were randomly distributed in mother and daughter cells, instead of 
being concentrated at the site of growth.  Conversely, cmd1-226 cells overexpressing MSS4 
(cmd1-226+pMSS4) exhibited a polarized actin cytoskeleton, as observed in wild-type 
CMD1 cells ( Figure 2).  Overexpression of MSS4 also suppressed the abnormal 
morphology of medium-sized buds on cmd1-226 mutant cells ( Figure 2).  Thus, consistent 
with the suppression of the cmd1-226 growth defect by MSS4, overexpression of MSS4 
suppresses the actin defect of cmd1-226 cells. 
 
Figure 3 Overexpression of PKC1, but not other members of the PKC1-activated 
MAPK pathway, suppresses a cmd1 mutation 
Wild-type (CMD1; DBY7462) cells and cmd1-226 (cmd1; DBY7446) cells carrying an empty 
vector or pCMD1, pROM2, pRHO2, pMSS4, pPKC1, pBCK1-20 (containing an activated allele of 
BCK1), pMKK1 or pMPK1 were streaked out on YPD and incubated at 24°C or at 37°C. 
These findings indicate that calmodulin and MSS4 are functionally related, particularly in 
the regulation of the organization of the actin cytoskeleton.  Furthermore, the above 
findings, combined with the observation that multicopy CMD1 failed to restore growth in a 
mss4ts mutant (results not shown), suggest that calmodulin may act upstream of MSS4. 
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Figure 4 Calmodulin regulates PtdIns(4,5)P2 levels in vivo 
Wild-type (CMD1; DBY7462) and cmd1-226 (DBY7446) strains were labelled at 24°C with 
[3H]inositol and transferred to 37°C.  Aliquots were collected at the indicated times, and the 
[3H]inositol-labelled lipids from cell extracts were deacylated and separated by HPLC.  
Radioactivity associated with each lipid was quantified and corrected to total levels of 
phosphatidylinositol found in the control samples.  Total phosphatidylinositol levels (c.p.m.) were 
as follows: CMD1, 0h, 663 147; 2h, 693 733; 4h, 687 418; cmd1-226, 0h, 753 572; 2h, 902 835; 4h, 
617 489.  Data represent means±S.E.M of two independent experiments. 
Calmodulin is required for synthesis of PtdIns(4,5)P2 in vivo 
To determine if calmodulin acts upstream of MSS4, we examined phosphoinositide levels 
in the cmd1-226 mutant.  Cells were labelled with [3H]inositol at 24°C, shifted to 37°C for 
various times, and assayed for phosphorylated phosphatidylinositol levels ( Figure 4).  As 
observed previously  (147), a temperature up-shift induced production of PtdIns(4,5)P2 in a 
wild-type strain (CMD1), due to activation of MSS4.  PtdIns(4,5)P2 levels increased 
approx.  2-fold within 1h of the temperature shift and remained at this level for at least 2h.  
In contrast, cmd1-226 cells failed to induce PtdIns(4,5)P2 synthesis upon temperature up-
shift, indicating that calmodulin regulates PtdIns(4,5)P2 levels.  The cmd1-226 mutation 
had little to no effect on the production of PtdIns3P, PtdIns4P and PtdIns(3,5)P2, indicating 
that calmodulin regulates specifically PtdIns(4,5)P2 levels.  These findings provide further 
evidence that calmodulin acts upstream of MSS4, in particular, as an activator of MSS4. 
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Calmodulin and MSS4 signal independently of the PKC1-activated mitogen-activated 
protein kinase (MAPK) cascade 
Organization of the actin cytoskeleton and cell integrity, both of which are affected in mss4 
and cmd1 mutants, are controlled in part by the PKC1-dependent MAPK cascade  (76).  
The PKC1-dependent MAPK cascade comprises BCK1/SLK1 (MAPK kinase kinase; 
'MAPKKK'), MKK1 and MKK2 (MAPK kinases; 'MAPKKs') and MPK1/SLT2 (MAPK)  
(262).  To investigate if calmodulin and MSS4 signal to the actin cytoskeleton via 
activation of this pathway, we examined whether overexpression of PKC1 or components 
of the MAPK cascade restore growth in cmd1-226 and mss4ts mutants.  As shown in Figure 
3, the growth defect of the cmd1-226 mutants is weakly suppressed by overexpression of 
PKC1.  Overexpression of components upstream of PKC1, such as the guanine nucleotide 
exchange factor ROM2 or the small GTPase RHO2, suppressed very weakly, if at all, the 
cmd1-226 mutation.  Expression of a constitutively active allele of BCK1 (BCK1-20) or 
overexpression of MKK1 or MPK1 failed to suppress cmd1-226 ( Figure 3).  
Overexpression of PKC1 or components of the MAPK cascade failed to suppress the mss4ts 
mutation (results not shown).  These results suggest that the growth defects of the cmd1-
226 and mss4ts mutants are not due solely to a lack of activation of the MAPK pathway 
downstream of PKC1.  To determine if calmodulin and MSS4 are required for the 
activation of the PKC1-dependent MAPK pathway, we assayed activation of MPK1 in 
cmd1-226 and mss4ts cells.  Shifting wild-type cells to 39°C for 1h resulted in activation of 
the cascade, as determined by Western blotting using an antibody specific for the activated 
form of MPK1  (263-265) (results not shown).  Elevated temperature induced activation of 
MPK1 in mss4ts cells to a level similar to that observed in wild-type cells.  The cmd1-226 
mutation resulted in an even stronger and longer activation of MPK1 (results not shown).  
These results indicate that calmodulin and MSS4 are not required for activation of the 
PKC1-dependent MAPK pathway.  However, calmodulin and possibly MSS4 may still 
signal via PKC1, but independently of the MAPK cascade, as suggested by the suppression 
of cmd1-226 by multicopy PKC1. 
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DISCUSSION 
We have shown previously  (147) that MSS4 is the only PtdIns(4)P 5-kinase in S. 
cerevisiae, and that it is required for proper organization of the actin cytoskeleton.  In the 
present study, we provide evidence that calmodulin activates MSS4-mediated synthesis of 
PtdIns(4,5)P2, and that it is via MSS4 that calmodulin controls the actin cytoskeleton.  First, 
cells lacking functional calmodulin or MSS4 proteins have similar phenotypes.  Secondly, 
overexpression of MSS4 restores both growth and actin organization in the cmd1-226 
mutant.  Finally, PtdIns(4,5)P2 levels are reduced in cells lacking calmodulin. 
How does calmodulin activate MSS4? Two models could explain how calmodulin regulates 
PtdIns(4,5)P2 synthesis.  First, calmodulin could activate a PtdIns 4-kinase that would, in 
turn, yield more substrate for MSS4.  Alternatively, calmodulin could activate MSS4 
independently of a PtdIns 4-kinase.  Several lines of evidence suggest that calmodulin does 
not activate a PtdIns 4-kinase.  First, unlike PtdIns(4,5)P2, total cellular levels of PtdIns4P 
do not increase upon shift of wild-type cells to 37°C.  Secondly, a calmodulin deficiency 
prevents heat-induced PtdIns(4,5)P2 accumulation, but does not cause a significant change 
in PtdIns4P levels.  Finally, overexpression of either one of the two S. cerevisiae PtdIns 4-
kinases, PIK1 and STT4, failed to suppress the growth defect of the cmd1-226 mutant 
(results not shown).  Thus calmodulin may activate MSS4 independently of the PtdIns 4-
kinases.  Frequenin, another member of the calmodulin superfamily, has been shown to 
bind and stimulate PIK1  (135).  This suggests that activation of PtdIns-kinases by Ca2+-
binding proteins may be a common theme.  However, we could not detect a direct 
interaction between calmodulin and MSS4 using the yeast two-hybrid system (results not 
shown), suggesting that calmodulin may not activate MSS4 directly. 
How do calmodulin and MSS4 control the organization of the actin cytoskeleton? One 
possibility is that they regulate the interactions between actin and the actin-binding 
proteins.  Cell motility and changes in morphology initiated by binding of extracellular 
ligands to transmembrane receptors, for example during the activation of platelets or 
neutrophils, require rearrangement of the actin cytoskeleton.  This is generally achieved by 
a transient increase in cytoplasmic Ca2+ concentration and by synthesis of PtdIns(4,5)P2.  
Ca2+ leads to solubilization of the cytoskeleton via activation of proteins that disrupt the 
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actin network and inhibition of actin cross-linking proteins.  Conversely, PtdIns(4,5)P2 
promotes actin polymerization by inhibiting actin-filament severing, capping and 
monomer-sequestering proteins (for review see  (266)).  The opposite effects of Ca2+ and 
PtdIns(4,5)P2 have led to a two-step model for the reorganization of the actin cytoskeleton 
during cell spreading or crawling  (267).  First, Ca2+ induces the release of actin filaments 
from the membrane and depolymerization of the cytoskeleton.  The second phase, 
characterized by repolymerization of actin, is triggered by synthesis and rearrangement of 
PPI.  Our previous observations in yeast cells undergoing thermal stress support this model  
(147,195).  Rearrangement of the actin cytoskeleton in response to heat is biphasic.  A rapid 
disappearance of actin cables and depolarization of the actin cytoskeleton is followed by an 
MSS4-dependent phase in which actin cables reappear and the cytoskeleton repolarizes.  
Our finding that calmodulin is required for heat-induced activation of MSS4 suggests that 
calmodulin is involved in the second phase of actin rearrangement and might act as a 
negative feedback regulator of Ca2+-induced actin depolarization and as a switch between 
actin depolarization and repolarization. 
The suppression, albeit weak, of cmd1-226 by multicopy PKC1 suggests that calmodulin 
and MSS4 may also signal to the actin cytoskeleton via PKC1.  PKC1 is activated by the 
GTP-bound form of the GTPase RHO1 or its homologue RHO2  (181,220).  Surprisingly, 
we found that overexpression of either RHO2 or its GDP/GTP exchange factor ROM2 did 
not suppress the cmd1-226 mutation.  This may suggest that there are different pools of 
PKC1 regulated by different mechanisms.  This notion is consistent with the observations 
that PKC1 displays punctate cytoplasmic localization and is also found associated with the 
plasma membrane at the site of bud growth, and that shifting cells to 37°C induces nuclear 
translocation only of PKC1 fractions initially localized at the plasma membrane (results not 
shown).  Thus MSS4 and RHO1/2 might activate different pools of PKC1.  However, if 
MSS4 does signal to the actin cytoskeleton via PKC1, this signaling appears to be 
independent of the PKC1-effector MAPK cascade, as MPK1 activation is not affected in 
cmd1 or mss4 mutants.  The existence of a calmodulin-activated PKC1-dependent pathway 
parallel to the MAPK cascade is consistent with an earlier suggestion that there is 
functional redundancy of the Ca2+- and MPK1-regulated pathways  (268).  The Ca2+- 
activated protein calcineurin and the PKC1-activated MAPK pathway act in concert to 
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regulate transcription of FKS2, which encodes a subunit of the 1,3-β-glucan synthase 
required for cell-wall synthesis  (269,270).  Calcineurin and MPK1 also act in synergy to 
control the onset of mitosis by activating the SWI1 transcription factor at the transcriptional 
and post-translational levels respectively  (271).  In addition, the phenotypes of glc7 cells, 
carrying a mutation in the catalytic subunit of type 1 protein serine/threonine phosphatase, 
suggests a role for this phosphatase in maintenance of cell-wall integrity, possibly via a 
PKC1-related pathway  (272). 
We also found that cells lacking functional MSS4 are defective in endocytosis.  This 
provides additional support for the idea that PtdIns(4,5)P2 is required for endocytosis.  An 
involvement of PtdIns(4,5)P2 in endocytosis was suggested previously by the finding that a 
dominant-negative isoform of PtdIns(4)P 5-kinase Iβ inhibits endocytosis of human colony-
stimulating factor 1 receptor  (259).  Furthermore, key components of the clathrin-mediated 
endocytic machinery are PtdIns(4,5)P2-binding proteins  (258,260).  Deletion of members 
of the synaptojanin inositol 5-phosphatases family in yeast also leads to reduced 
endocytosis  (64), suggesting a role for PtdIns(4,5)P2 turnover in endocytosis.  Targeted 
disruption of the synaptojanin 1 gene in mice leads to death shortly after birth  (70).  
Neurons of mutant animals have elevated levels of PtdIns(4,5)P2 and accumulate clathrin-
coated vesicles at the synaptic vesicle cluster, the site where clathrin-mediated 
internalization of the synaptic vesicle membrane occurs.  Interestingly, cells lacking 
calmodulin, like mss4ts mutants, are defective in endocytosis  (250,251).  It remains to be 
determined if calmodulin also regulates endocytosis via activation of MSS4. 
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3.          MSS4 regulation and PI(4,5)P2 effector in  
Saccharomyces cerevisiae 
 
PI(4,5)P2 synthesis and turnover are well studied processes and are important in several 
cellular processes such as the organization of the actin cytoskeleton.  In mammalian cells 
many PIP5K isoforms exist and they are suggested to be regulated by the RHO GTPase 
family and phosphatidic acid (see 1.3.1).  In Saccharomyces cerevisiae there is only one 
PIP5K, MSS4, (see 1.4.1.2 Fig 5) but the regulation is not thoroughly characterized.  We 
wanted to understand in more detail how MSS4 is regulated and to identify and characterize 
possible interaction partner/s.  In addition, we have studied possible effector/s of PI(4,5)P2 
which could link MSS4 function to the signaling cascade of TOR2 and the cell wall 
integrity pathway.  
 
3.1 MSS4 can be part of a complex  
 
Mammalian PIP5K interact with different proteins but the interaction modules have not 
been described.  Upon heat shock, a shift from 24°C to 37°C, PI(4,5)P2 levels increase 
dramatically (147).  This suggests that the PI(4,5)P2 synthesis might be regulated.  MSS4 
does not contain any known protein interaction module.  Therefore we undertook the study 
if MSS4 could be part of a complex by using gel filtration chromatography.  We observed 
that MSS4 eluted as a high molecular weight fractions of approximately 1000 kDa 
indicating the possibility that it could be part of a complex (Fig 3.1A).  Detergent was 
added to these experiments to avoid aggregations that could be caused by lipid interaction.  
To investigate if this observation could be the result of dimerization of MSS4 co-
immunoprecipitation experiments was carried out.  A strain with MSS4 genomically tagged 
with TAP module was transformed with a plasmid containing HA-tagged MSS4.  The co-
immunoprecipitation experiment revealed no interaction between these two differentially 
tagged MSS4 (Fig 3.1B).  Subsequently, we performed high scale purification to identify 
putative interaction partners.  MSS4 tagged at the N-terminal with 3XHA was used for 
purification with cation exchange chromatography (which had been proven to give highly 
purified protein) and in parallel N-terminal (tandem affinity purification) TAP-tagged 
MSS4 regulation and PI(4,5)P2 effectors 
_________________________________________________________________________ 
_________________________________________________________________________ 
47 
MSS4 was purified.  These purifications were repeated several times but no interaction 
partner was identified (data not shown).  These results indicate that MSS4 is might be part 
of a complex and the component/s of the complex remains to be characterized. 
IP       9       10      11    12    13      14     15       16       17 18      19
HA-MSS4
A
B
HA-MSS4
TAP-MSS4
+    - +     +    +
- +    +     - +
+    - +     +    +
- +    +     - +
IP  IgG IP α-HA
α-HA α-protein A
669 kDa
 
Figure 3.1 MSS4 is part of a complex.  
(A) Gel filtration chromatography using a strain expressing HA-MSS4 (146). Each fraction 
immunoprecipitated with HA-antibody, visualized with HA antibody (see Experimental procedures). (B) 
3XHA-MSS4 (146) expressed in strain containing genomic TAP-MSS4  
 
3.2        Effectors of PI(4,5)P2 
 
MSS4 was previously shown to suppress the growth defect upon loss of TOR2 function 
(179).  To understand the link between MSS4 in TOR2 signaling pathway and/or the cell 
wall integrity pathway we were interested in identifying the effectors of PI(4,5)P2-
signaling.  For this study we focused first on characterization of known PH domain 
containing proteins.  One of the putative PI(4,5)P2-targets is the GEF of RHO1 ROM2 
which is downstream of WSC1 and TOR2 (209).  Since actin cytoskeleton is depolarized in 
a conditional mutant of mss4 we used CAP2 as an indicator of the actin distribution.  CAP2 
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localizes to the growing ends of actin filaments.  ROM2 was tagged with yellow 
fluorescence protein (YFP) to compare simultaneously the localization of CAP2-CFP 
(cyano fluorescence protein).  ROM2-YFP localizes to the bud tip and to the bud neck of 
small budded cells (Steffen Fredersdorf,unpublished results and Fig 3.2).  To test if the 
levels of PI(4,5)P2 are important for ROM2 localization it was observed in a MSS4 mutant.  
Whereas in wild type, ROM2 localized to the bud tip and bud neck we observed a cytosolic 
signal of ROM2 upon loss of MSS4 function (Fig 3.2). This result suggests that PI(4,5)P2 is 
important for proper localization of ROM2 and a link between MSS4 function and TORC2 
signaling pathway  
ROM2-YFP
CAP2-CFP
phase
24 ºC 1 hr at 38 °C  3 hr at 38  ºC 5 hr at 38 ºC
Figure 3.2 ROM2 localization is dependent on PI(4,5)P2 synthesis.   
Wild type cells (TB50) and  mss4ts were grown at 24°C, shifted to 37°C at the indicated time and processed 
for detection of ROM2-YFP and CAP2-CFP (see Experimental procedures).    
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Experimental Procedures 
 
Strains, media 
The Saccharomyces cerevisiae strains used in this study are listed in Table I.  All strains 
were isogenic derivatives of TB50.  Rich media (YPD) and SD medium was as described 
previously (273).  For tagging of MSS4 a PCR-fragment containing TAP was introduced at 
the N-terminus between promoter and START as described elsewhere (274).  Yeast 
transformation was performed by the lithium acetate procedure (275).  Correct integration 
was verified by PCR.   
 
 
Gel filtration chromatography 
Cells expressing a tagged version of MSS4 were grown in 500 ml of YPD to  A600 of 0.8 at 
30°C and harvested by centrifugation, and washed with cold water before resuspension in 
lysis buffer.  Lysis buffer used to prepare cell extracts was PBS , 5% glycerol, 0.5% Tween 
20 and phosphatase inhibitors (10 mM NaF, 10 mM NaN3, 10 mM p-nitrophenylphosphate, 
10 mM sodiumpyrophosphate, 10 mM ß-glycerophosphate and 1 mM 
phenylmethylsulfonyl fluoride) and protease inhibitor cocktail tablets (Roche).  Cell lysate 
was obtained by glass bead lysis.  Cell lysates were cleared with a 5 min, 500Xg spin, and 
the supernatant was passed through a 0.22 µm filter.  Five milligrams of protein (in a 
volume of less than 0.5 ml) was loaded onto a Superose 6 HR 10/30 column (Amersham 
Pharmacia Biotech).  The flow rate was adjusted to 0.2 ml/minute, and fractions of 1 ml 
were collected.  Elution profiles were analyzed by immunoprecipitation (1 hr incubation) 
and immunoblot and compared to the elution profile of known standards.  
 
Immunoprecipitations 
Yeast extracts from 500 ml culture grown in YPD to A600 of 0.8 at 30°C expressing tagged 
proteins of interest were prepared.  An aliquot of extract containing 10 mg of protein was 
adjusted to 1 ml with lysis buffer plus inhibitors.  For immunoprecipitations, 20 µl anti-HA 
(12CA5) cross-linked to Protein A-sepharose beads or 20 µl IgG Sepharose 6 fast flow 
(Amersham Pharmacia Biotech) were added and mixed for 4 hrs at 4°C.  Beads were 
collected by centrifugation, washed extensively, and resuspended in 5X SDS-PAGE sample 
buffer for electrophoresis.  After SDS-PAGE, proteins were blotted onto nitrocellulose 
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membranes, blocked in 5% dry milk powder in 1X PBS and 0.1% NP40, and incubated 
with primary antibody anti-HA (12CA5) or anti-protein A 1:10000 in blocking solution).  
Subsequently tagged proteins were detected using horseradish peroxidase-conjugated goat 
anti-mouse secondary antibodies and ECL reagents (Amersham Pharmacia Biotech). 
 
Fluorescence microscopy 
Cells of various strains were grown at 24°C in YPD.  At A600 of 0.2, cells were shifted to 
37°C for the time indicated.  1 ml aliquots were collected, cells were spun down and the 
pellet resuspended in SD medium to decrease background signal.  YFP and CFP signal was 
visualized using fluorescence microscopy. 
 
TABLE I 
 
STRAIN GENOTYPE 
TB50  MATa leu2-3,112 uta3-52 trp1 his3 rme1 HMLa 
HM16-1C TB50 a  mss4::HIS/ pRS314::3XHA-MSS4 URA3 
HM31-1C TB50a TAP-MSS4  
HM20-1C 
TB50a mss4::HIS3MX6/YCplac111::MSS4/ ROM2-YFP  HIS 
/CAP2-CFP HIS 
HM21-3B 
TB50a mss4::HIS3MX6/YCplac111::mss4-2ts 
/ROM2-YFP HIS/CAP2-CFP HIS 
HM29-3D TB50a ROM2-YFP HIS/CAP2-CFP HIS 
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4. Negative regulation of PI(4,5)P2 levels by the INP51-
associated proteins TAX4 and IRS4 
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Abstract 
Phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P2) is an important second messenger in 
signaling pathways in organisms ranging from yeast to mammals, but the regulation of 
PI(4,5)P2 levels remains unclear.  Here we present evidence that PI(4,5)P2 levels in 
Saccharomyces cerevisiae are downregulated by the homologous and functionally 
redundant proteins TAX4 and IRS4.  The EPS15 homology (EH) domain containing 
proteins TAX4 and IRS4 bind and activate the PI(4,5)P2 5-phosphatase INP51 via an NPF 
motif in INP51.  Furthermore, the INP51-TAX4/IRS4 complex negatively regulates the cell 
integrity pathway.  Thus, TAX4 and IRS4 are novel regulators of PI(4,5)P2 and PI(4,5)P2-
dependent signaling.  Furthermore, the interaction between TAX4/IRS4 and INP51 is 
analogous to the association of EPS15 with the 5-phosphatase synaptojanin in mammalian 
cells, suggesting that EPS15 is an activator of synaptojanin. 
 
Introduction 
Phosphoinositides are conserved from yeast to mammals as second messengers.  They 
mediate signal transduction involved in many different cellular processes and thereby 
comprise a complex signaling system (6 45).  One of the more thoroughly studied 
phosphoinositides is phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P2).  PI(4,5)P2 was 
originally shown to be cleaved by phospholipase C to generate the two second messengers 
inositol-1,4,5- phosphate (IP3) and diacylglycerol (DAG) (233).  More recently, uncleaved 
PI(4,5)P2 has also been shown to act as a second messenger (150,276).  Uncleaved 
PI(4,5)P2 acts by binding conserved domains in target proteins, such as the pleckstrin 
homology (PH) domain (10).  In mammalian cells, PI(4,5)P2 signaling is important in 
regulating vesicular transport, the organization of the actin cytoskeleton, and regulation of 
ion channels (19,67,277).  In the model organism Saccharomyces cerevisiae, PI(4,5)P2 is 
also essential and is produced by MSS4, the sole phosphatidylinositol 4-phosphate 5-kinase 
(PI4P 5-kinase) in yeast (147) (146).  
One target of PI(4,5)P2 signaling in Saccharomyces cerevisiae is the GDP/GTP 
exchange factor (GEF) ROM2.  ROM2 contains a pleckstrin homology (PH) domain that 
binds PI(4,5)P2 in the plasma membrane thus mediating the localization of ROM2 {Ozaki, 
1996 #103} (132).  ROM2 has two homologs, ROM1 and TUS1, that also harbour a 
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putative PH-domain {Ozaki, 1996 #103}(210).  ROM2 and its homologs are components of 
the cell integrity pathway necessary for the cellular response to cell wall damage induced 
by stress such as heat shock (204,210).  The response to cell wall damage includes a 
reorganization of the actin cytoskeleton and an upregulation of cell wall synthesis 
(183,191,195,278).  Activation of the cell integrity pathway is mediated by its most 
upstream component, the cell wall sensor WSC1, that signals to ROM2 (265,279).  
Subsequently, ROM2 stimulates the exchange of GDP to GTP in the Rho GTPase RHO1, 
thereby activating RHO1 {Ozaki, 1996 #103}.  The GTPase-activating protein (GAP) 
SAC7 converts RHO1-GTP into the inactive GDP-bound form (209).  RHO1 in its active 
(GTP-bound) form has several effectors such as the glucan synthase FKS1 and the PKC1-
MAP kinase cascade (280) (181,214,220).  Activation of the MAP kinase MPK1 induces 
transcription of genes involved in cell wall biosynthesis, such as CHS3 encoding chitin 
synthase III important for cell wall repair (191,192,278). 
The ROM2-MAP kinase-signaling pathway is also an effector branch of the TOR 
signaling network.  The TOR signaling network contains two structurally and functionally 
distinct complexes, TOR complex 1 (TORC1) and 2 (TORC2).  TORC2 regulates the 
polarization of the actin cytoskeleton, and this regulation is via the ROM2-MAP kinase 
pathway (179,232).  Interestingly, the PI4P 5-kinse MSS4 is required for the polarization of 
the actin cytoskeleton, and overexpression of MSS4 restores growth in conditional TORC2 
mutants (147,179) (146,232).  However, the link between PI(4,5)P2 and TORC2 in the 
regulation of ROM2 and ultimately the actin cytosekeleton is not understood. 
The phosphoinositide 5-phosphatases INP51, INP52 and INP53 mediate the 
turnover of PI(4,5)P2 and are implicated in several cellular processes such as cell wall 
biosynthesis and the organization of the actin cytoskeleton (153,168).  Heat shock has been 
observed to induce an increase in PI(4,5)P2 levels, suggesting the existence of a mechanism 
regulating the levels of this phosphoinositide (147).  However, the nature of this regulatory 
mechanism and, more specifically, the possible regulation of the phosphoinositide 5-
phosphatases are not well understood.  In mammalian cells, the INP family orthologue 
synaptojanin 1, interacts with several proteins involved in endocytosis in nerve terminals 
(66,71,74).  To investigate the regulation of PI(4,5)P2 turnover in Saccharomyces 
cerevisiae, we focused on INP51, INP52 and INP53 and their role in PI(4,5)P2 signaling 
linked to the cell integrity pathway and the TORC2 pathway. 
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Here we present evidence for two novel positive regulators of the PI(4,5)P2 5-
phosphatase INP51, the redundant EPS15 homology (EH) domain-containing proteins 
TAX4 and IRS4.  INP51 associates with TAX4 or IRS4 to form two complexes important 
for the turnover of PI(4,5)P2 linked to the cell integrity pathway. 
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Experimental Procedures 
 
Strains and media 
The Saccharomyces cerevisiae strains used in this study are listed in Table I.  All strains 
were isogenic derivatives of TB50.  Rich medium (YPD) and SD medium were as 
described previously (253).  PCR cassettes were used to generate gene deletions and for 
tagging with HA, myc or TAP, as described (Wach 1994) (281)(Puig 2001).  Yeast 
transformation was performed by the lithium acetate procedure (275).  Correct integration 
was verified by PCR and tagged proteins were tested for their functionality. 
 
Spot assay 
Logarithmically growing cells were harvested and resuspended in 10 mM TRIS pH 7.4.  
The resuspended cells were diluted in a tenfold dilution series.  3 µl of each dilution (10x, 
100x, 1,000x and 10,000x diluted) were spotted on an YPD plate.  Growth was scored after 
two days at 30°C or 37°C. 
 
INP51 purification 
Cells expressing a tagged or untagged (mock purification) version of INP51 were grown in 
five litres of YPD to A600 of 0.8 at 30°C and harvested by centrifugation, and washed with 
cold water before resuspension in lysis buffer.  Lysis buffer used to prepare cell extracts 
was PBS, 5% glycerol. 0.5% Tween 20 and phosphatase inhibitors (10 mM NaF, 10 mM 
NaN3, 10 mM p-nitrophenylphosphate, 10 mM sodiumpyrophosphate, 10 mM ß-
glycerophosphate 1 mM phenylmethylsulfonyl fluoride) and protease inhibitor cocktail 
tablets (Roche).  Cell lysate was obtained by glass bead lysis.  Cell lysates containing 
approximately 700 mg protein were cleared with a 5 min, 500Xg spin, diluted with lysis 
buffer to 10 mg/ml, and subsequently passed over an ion exchange resin (SP-sepharose).  
The resin was washed twice with lysis buffer and twice with lysis buffer containing 50 mM 
potassium acetate. Bound proteins were eluted with lysis buffer containing 600 mM 
potassium acetate.  The eluate was precleared over a Protein A-Sepharose (Amersham 
Pharmacia Biotech) column prior to the addition of anti-HA (12CA5) cross-linked to 
Protein A-sepharose beads. After 5X washing with lysis buffer, immunoprecipitated 
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proteins were visualized by silver staining (282).  Analysis of protein bands by mass 
spectrometry was performed as described (232). 
 
Immunoprecipitation 
Yeast extracts from cells (500 ml culture in YPD grown to A600 of 0.8 at 30°C) expressing 
tagged proteins of interest were prepared. An aliquot of extract containing 10 mg of protein 
was adjusted to 1 ml with lysis buffer plus inhibitors.  For immunoprecipitations, 20 l 
anti-HA (12CA5) or anti-myc (9E10) cross-linked to Protein A-sepharose beads were 
added and mixed for 4 hrs at 4°C.  Beads were collected by centrifugation, washed five 
times with 1 ml lysis buffer, and resuspended in 5X SDS-PAGE sample buffer for 
electrophoresis.  After SDS-PAGE proteins were blotted onto nitrocellulose membranes, 
blocked in 5% dry milk powder in 1 X PBS and 0.1% NP40, and incubated with primary 
antibody anti-HA (clone 12CA5) or anti-myc (clone 9E10) 1:10000 in blocking solution).  
Subsequently tagged proteins were detected using horseradish peroxidase-conjugated goat 
anti-mouse secondary antibodies and ECL reagents (Amersham Pharmacia Biotech).  
 
Phosphoinositide analysis 
Strains were grown at 30°C to A600 of 0.7 in medium containing 50 µCi/ml [3H]Inositol 
(Amersham). The cells were harvested by centrifugation and resuspended in one-fifth of the 
original volume. Aliquots (200 µl) were collected, and the cells were arrested by the 
addition of 500 µl of methanol. After drying samples in vacuo, lipid extraction and analysis 
were performed as described previously (127). 
 
Differential centrifugation 
Differential centrifugation was performed as described previously (283). 
 
Indirect immunofluorescence 
Logarithmically growing cells containing HA-INP51, myc-TAX4 or myc-IRS4 were fixed 
for 2 h in the growth medium supplemented with formaldehyde (3.7% final) and potassium 
phosphate buffer (100 mM final, pH 6.5). Cells were washed and resuspended in sorbitol 
buffer (1.2 M sorbitol and 100 mM potassium phosphate, pH 6.5). Cell walls were digested 
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for 45 min at 37°C in sorbitol buffer supplemented with ß-mercaptoethanol (20 mM final) 
and zymolyase 20T (12.5 mg/ml; Seigagaku Corporation). Spheroblasts were fixed on poly-
L-lysine–coated glass slides and permeabilized with PBT (53 mM Na2HPO4, 13 mM 
NaH2PO4, 75 mM NaCl, 1% BSA, and 0.1% Triton X-100). Immunofluorescence directed 
against the HA-epitope was performed by application of a primary antibody anti-HA (clone 
12CA5) or anti-myc (clone 9E10) at a dilution of 1:1,000 in PBT for 2 h, and subsequently 
of a Cy3-conjugated rabbit anti–mouse IgG (Molecular Probes), diluted 1:1,000 in PBT, for 
90 min.  Washed cells were examined with a Zeiss Axiophot microscope (100X objective).  
Immunofluorescent detection of FKS1 was performed as described previously (195).   
 
MAP kinase activation assay 
YPD cultures of logarithmically growing cells at 24°C were harvested and cell extracts 
were prepared as described previously (263).  Protein concentrations of extracts were 
determined by using Bradford Assay (BIO-RAD).  Samples were denatured by addition of 
5X SDS-polyacrylamide gel electrophoresis (PAGE) sample loading buffer and heating at 
95°C for 5 min.  A total of 25 g of protein (for MPK1 protein detection) or 40 g of 
protein (for phosphorylated MAPK detection) was loaded for standard SDS-PAGE (10% 
acrylamide) and Western blot (Ausubel et al 1998).  For immunodetection, a goat anti-
MPK1 antibody (clone yN-19, 1:1000 dilution; Santa Cruz) and rabbit anti-phospho-p44/42 
MAP kinase (THR202/Tyr204) antibody (1:1000; Cell Signaling) were used.  The anti-
MPK1 and anti-phospho MAPK were verified to specifically recognize activated MPK1 
under heat stress conditions (data not shown).  Secondary antibodies were horseradish 
peroxidase-conjugated anti-goat (anti-MPK1) or anti-rabbit (anti-phospho MAPK) 
secondary antibody and detection by ECL reagents (Amersham Pharmacia Biotech). 
 
Actin staining 
Logarithmically growing cells were fixed in formaldehyde (3.7%) and potassium phosphate 
buffer (100 mM, pH 6.5), and stained with TRITC-phalloidin (Sigma) to visualize actin, as 
described previously (257). 
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Chitin staining 
1 ml of cells at A600 of 0.5 were collected by centrifugation and washed with water.  Cells 
were then incubated in a solution with 0.5 mg/ml calcofluor white (CFW; Sigma) for 5 min 
to visualize chitin.  To remove residual CFW, cells were washed twice with water.  Cells 
were examined with a Zeiss Axiophot microscope (100X objective). 
 
Results 
 
Disruption of INP51 restores growth of a tor2 mutant 
To understand further how turnover of PI(4,5)P2 is important for PI(4,5)P2 signaling.  We 
tested if the phosphoinositide 5-phosphatase INP51, INP52 or INP53 antagonizes MSS4 
signaling.  We asked if the lack of any INP gene mimics MSS4 overexpression in 
suppressing a TOR2 signaling defect.  A deletion of each INP gene was introduced into a 
temperature-sensitive tor2 (tor2ts) mutant defective in the organization of the actin 
cytoskeleton.  The double mutants were grown at permissive (30°C) and restrictive 
temperatures (37°C) to determine if INP mutations can suppress the tor2ts mutation.  
Deletion of only INP51, INP52 or INP53 conferred no growth defect at any temperature 
(data not shown).  Interestingly, deletion of INP51, but not deletion of INP52 or INP53, 
suppressed the growth defect of tor2ts cells.  The inp51 tor2ts cells grew almost as well as 
wild type cells and as well as tor2ts cells overexpressing MSS4 (Fig. 1 and data not shown).  
This suggests that INP51, but not INP52 or INP53, antagonizes the role of MSS4 in the 
TORC2 signaling pathway.  Curiously, although inp51 suppressed the growth defect of a 
tor2ts, it did not appear to suppress the actin defect of the tor2ts mutant (data not shown). 
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Figure 1. Disruption of INP51 restores growth of a tor2 conditional mutant. 
Cells from  wild-type (TB50a), inp51, tor2ts, tor2ts inp51 and tor2ts transformed with pMSS4 were 
serially diluted in YPD liquid medium, spotted onto YPD medium and incubated at 30 °C or 37 
°C.  tor2ts cells are not viable at 37 °C. 
 
INP51 synthetically interacts with mutations affecting the cell integrity pathway  
The finding that an inp51 deletion suppresses the growth defect of a tor2ts mutant is similar 
to the previous observation that activation of the cell integrity pathway suppresses the 
growth defect of a tor2ts mutant (204), and suggests that INP51 may antagonize the cell 
integrity pathway.  Thus, we investigated if an inp51 mutation interacts with mutations 
affecting components of the cell integrity pathway.  Specifically, we asked if an inp51 
deletion suppresses or enhances the effect of mutations in WSC1, ROM2, SAC7 or MPK1.  
We observed that deletion of INP51 suppresses the growth defects of wsc1 and rom2 cells 
at 37°C and 30°C, the restrictive temperatures of these mutants, respectively (Fig. 2A).  
Conversely, the combination of inp51 with sac7 conferred a synthetic growth defect (Fig. 
2C).  Finally, the growth defect of an mpk1 mutant grown at restrictive temperature (38°C) 
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was not suppressed by INP51 deletion (data not shown).  The above results show that 
INP51 genetically interacts with at least some components of the cell integrity pathway.  
Deletion of INP51 suppresses mutations in positive components of the pathway (WSC1 and 
ROM2) and causes a synthetic defect when combined with a mutation in a negative element 
of the pathway (SAC7).  The nature of these interactions suggests that the phosphoinositide 
phosphatase INP51 negatively regulates signaling through the cell integrity pathway.  This 
conclusion is consistent with the previous conclusions (120,179,232) (132) that the 
phosphoinositide kinase MSS4 and PI(4,5)P2 act positively on the TORC2 and cell integrity 
pathways. 
rom2 sac7
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Figure 2. INP51 synthetically interacts with components of the cell wall integrity 
pathway.  
(A) Wild-type, inp51, wsc1 and wsc1 inp51 cells were serially diluted in YPD liquid medium, 
spotted onto YPD medium and grown at 30 °C or 37 °C.  wsc1 cells have a growth defect at 37 °C.  
(B) Wild-type, inp51, rom2 and rom2 inp51 cells were grown on YPD medium at 30°C.  rom2 cells 
have a growth defect at 30 °C.  (C) Wild-type, inp51, sac7 and sac7 inp51 cells were grown on 
YPD at 30 °C. 
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INP51 associates with the EH domain-containing proteins TAX4 and IRS4 
In mammalian cells, the kinases and phosphatases that determine PI(4,5)P2 levels are 
regulated by interacting proteins (69,71,245,284-286).  Indication that the level of PI(4,5)P2 
is regulated in Saccharomyces cerevisiae has been suggested previously by the observation 
that PI(4,5)P2 levels increase upon heat shock (147).  However, proteins regulating such 
kinases and phosphatases in Saccharomyces cerevisiae remain to be identified.  To identify 
potential INP51 regulatory proteins, we opted to isolate INP51 interacting proteins using a 
biochemical approach described previously (232).  A functional, epitope-tagged version of 
INP51 (INP51-HA) was constructed and purified from yeast cell extracts as described in 
Experimental Procedures.  Two homologous proteins co-purified with INP51, IRS4 and an 
uncharacterized protein encoded by the open reading frame YJL083w (Fig. 3) which we 
named TAX4.  The interaction between INP51 and TAX4 or IRS4 was confirmed by co-
immunoprecipitation using epitope-tagged versions of TAX4 (TAX4-myc) and IRS4 
(IRS4-myc), as described in Experimental Procedures (Fig. 4).  We did not observe 
interaction between TAX4 and IRS4 by co-immunoprecipitation of heterologously tagged 
versions (TAX4-TAP and IRS4-myc) of these proteins (data not shown).  IRS4 was 
previously identified in a screen for mutants involved in rDNA silencing as a mutant with 
increased rDNA silencing (287).  Untagged TAX4 has an apparent molecular weight of 77 
kDa and a predicted size of 68.7 kDa.  Untagged IRS4 is observed as two bands between 70 
and 75 kDa, slightly larger than the predicted size of 68.8 kDa.  TAX4 and IRS4 have an 
overall identity of 31% and contain a C-terminal EPS15 homology (EH)-domain.  The EH 
domains of TAX4 and IRS4 are 64% identical.  The EH domain, conserved from yeast to 
human, is a protein-protein interaction domain of approximately 100 amino acids that 
interacts specifically with short motifs containing an asparagine-proline-phenylalanine 
(NPF) core (288,289).  INP51 has a C-terminal NPF motif (290) which is important for the 
interaction between INP51and TAX4 or IRS4.  The absence of the NPF motif in INP51 
abolishes the interaction between INP51 and TAX4 or IRS4, as assayed by co-
immunoprecipitation (data not shown).  Our results shows that INP51, via its NPF-motif, 
interacts separately with the two EH domain-containing proteins TAX4 and IRS4, 
suggesting that INP51 forms separate INP51-TAX4 and INP51-IRS4 complexes. 
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There are additional EH-containing proteins in Saccharomyces cerevisiae, including 
PAN1, END3 and EDE1 (257,291,292).  Interestingly, a conditional pan1 mutation shows 
synthetic interaction with an inp51 mutation (158).  Since PAN1 and END3 belong to the 
same protein complex, we tested if PAN1 and/or END3 interact with INP51.  We could not 
detect, by co-immunoprecipitation, an interaction between INP51 and PAN1 or END3, 
suggesting that INP51 interacts specifically with TAX4 and IRS4. 
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Figure 3. INP51 copurifies with two proteins, TAX4 and IRS4. 
Silver stained gel of INP51-HA purification (see Experimental Procedures) from TB50 cells (wild-
type) and HM47-1C cells (INP51-HA).  Protein bands unique to the INP51-HA purification are 
indicated.  These bands were excised and identified by mass spectrometry (see Experimental 
Procedures). 
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Figure 4. INP51 co-immunoprecipitates with TAX4 and IRS4. 
(A) Lysates from cells expressing INP51-HA (HM47-1C), TAX4-myc (HM92-), IRS4-myc (HM104-2D) or 
co-expressing INP51-HA and TAX4-myc (HM96-1B), or INP51-HA and IRS4-myc (HM119-2B) were 
subjected to coimmunoprecipitation by immunoprecipitation (IP) with anti-myc and immunoblot (IB) with 
anti-HA or IP with anti-HA and IB with anti-myc.  (B) For expression controls each strain in (A) was 
subjected to anti-myc IP and IB with anti-myc or IP with anti-HA and probed with anti-HA. 
 
TAX4 and IRS4 positively regulate INP51 
The interaction of INP51 with TAX4 and IRS4 led us to examine a possible involvement of 
TAX4 and IRS4 in the function of INP51.  TAX4 and IRS4 are non-essential genes, as 
shown previously (293).  Furthermore, cells lacking both TAX4 and IRS4 (a tax4 irs4 
double mutant) did not confer a detectable growth defect on standard rich or minimal media 
at various temperatures (Fig. 6 and data not shown). 
To determine the function of TAX4 and IRS4, we measured the levels of all 
detectable S. cerevisiae phosphoinositides, PI(3)P, PI(4)P, PI(3,5)P2 and PI(4,5)P2, in 
inp51, tax4, irs4 and tax4 irs4 mutant cells.  The double mutant tax4 irs4 was examined 
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anticipating the likelihood that the structurally homologous TAX4 and IRS4 proteins are 
also functionally homologous.  We observed that an inp51 mutant has higher levels of 
PI(4,5)P2 than wild type, as observed previously (156), but is not altered in the levels of 
other phosphoinositides (Fig. 5).  The deletion of TAX4 or IRS4 did not affect the level of 
any phosphoinositide.  However, the double deletion mutant tax4 irs4, like the inp51 
mutant, exhibited a significant and specific increase in the level of PI(4,5)P2.  Our data 
suggest that TAX4 and IRS4 indeed act redundantly, as positive regulators of INP51 
activity and thereby PI(4,5)P2 turnover. 
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Figure 5 PI(4,5)P2 level is increased in an inp51 mutant and in a tax4 irs4 mutant.   
Wild-type (WT), inp51, irs4, tax4 and tax4 irs4 cells were labeled at 30°C with [3H]inositol, and 
[3H]inositol–containing lipids from the cell extracts were deacylated, separated by HPLC, and 
quantified.  
 
Since TAX4 or IRS4 appears to be required for INP51 activity, we asked if the tax4 
irs4 double mutation, like inp51, genetically interacts with TOR2 and components of the 
cell integrity pathway.  We combined the tax4 irs4 double mutation with tor2ts, rom2, or 
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sac7.  In agreement with the positive role of TAX4 and IRS4 on INP51 activity, tax4 irs4 
suppressed the growth defect of a tor2ts mutant at non-permissive temperature (Fig. 1 and 
6), to the same extent as deletion of INP51 or overexpressed MSS4.  The growth defect of a 
rom2 mutant was also suppressed by tax4 irs4 mutation.  Finally, combination of tax4 irs4 
with a sac7 mutation produced a synthetic growth defect similar to the combination of 
inp51 and sac7 (Fig. 2 and 7).  Deletion of TAX4 or IRS4 alone showed no synthetic 
interaction with components of the cell integrity pathway (data not shown).  Our results 
suggest that TAX4 or IRS4, like INP51, is important for PI(4,5)P2 turnover linked to 
TORC2 signaling and the cell integrity pathway. 
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Figure 6. Deletion of TAX4 and IRS4 restores growth of a tor2  conditional mutant. 
Cells from wild-type, inp51, tax4 irs4, tor2ts, tor2ts inp51, tor2ts tax4 irs4 and tor2ts transformed with pMSS4, 
were serially diluted in YPD liquid medium, spotted onto YPD medium and grown at 30 °C or 37 °C.  tor2ts 
cells are not viable at 37 °C. 
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To investigate the mechanism by which TAX4 and IRS4 regulate INP51, we 
examined the cellular localization of TAX4, IRS4 and INP51, by indirect 
immunofluorescence on strains expressing epitope-tagged versions of these proteins.  We 
observed an intracellular punctate staining pattern for both TAX4 and IRS4.  However, for 
unknown reasons, we were unable to detect a signal for INP51, and were thus unable to 
determine by this assay if TAX4 or IRS4 is required for the correct localization of INP51.  
By differential centrifugation (see Experimental Procedures), we observed that INP51 is a 
cytosolic protein and this localization did not change in a tax4 irs4 double mutant, 
suggesting that TAX4 or IRS4 does not regulate the subcellular localization of INP51. 
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 Figure 7 Null mutation of both TAX4 and IRS4 interacts synthetically with SAC7 
deletion mutant.   
Wild-type, sac7, inp51, sac7 inp51, tax4 irs4 and sac7 tax4 irs4 were serially diluted in YPD liquid medium, 
spotted onto YPD medium and grown at 30 °C.  
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INP51, TAX4 and IRS4 negatively regulate MPK1 
The genetic interactions described above suggest that INP51, TAX4 and IRS4 negatively 
regulate signaling through the cell integrity pathway.  However, the above experiments 
(and data not shown for TAX4 and IRS4) did not reveal a genetic interaction between 
MPK1 and the INP51 complexes.  To investigate further a possible functional interaction 
between MPK1 and the INP51 complexes, we examined MPK1 phosphorylation in wild 
type cells and in mutant cells containing rom2, sac7, inp51, tax4, irs4, tax4 irs4, or any 
possible combination of rom2 or sac7 with inp51, tax4, irs4, or tax4 irs4.  Upon stimulation 
of the cell integrity pathway MPK1 is phosphorylated and thereby activated (222).  MPK1 
phosphorylation was analyzed with an antiphospho p44/p42 MAPK antibody that also 
specifically recognizes the phosphorylated form of MPK1.  The amount of total MPK1 was 
assayed with a separate antibody that recognizes all forms of MPK1.  As shown previously, 
MPK1 phosphorylation is almost undetectable in wild type cells grown at 23°C (non-
inducing condition) but increases upon shift to 39°C (222).  We examined the 
phosphorylation state of MPK1 in wild type cells and mutant cells grown at low 
temperature (24°C) and at high temperature (39°C).  The level of MPK1 phosphorylation in 
heat shocked cells (shift to 39°C for 30 minutes and 60 minutes) was not altered in any of 
the mutants examined (data not shown).  However, the sac7, sac7 inp51, sac7 tax4 irs4 
mutations affected the basal level (24°C) of MPK1, as follows.  A sac7 mutation resulted in 
a slight increase in MPK1 phosphorylation but also a similar increase in the amount MPK1 
protein, compared to wild type (Fig. 8).  The sac7 inp51 and sac7 tax4 irs4 cells exhibited a 
10 fold increase in MPK1 phosphorylation and a 2.5 fold increase in MPK1 protein level 
compared to the sac7 cells.  Thus, inp51 and tax4 irs4 mutations cause constitutive MPK1 
activity, although this effect is detectable only when inp51 and tax4 irs4 are combined with 
a sac7 mutation.  Furthermore, as suggested by some of the genetic interactions described 
above, these findings confirm that INP51 complexes indeed negatively regulate signaling 
through MPK1 and the cell integrity pathway. 
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Figure 8. MPK1 phosphorylation and protein level increases in inp51 sac7 deletion 
mutant and tax4 irs4 sac7 deletion mutant.  
MPK1 activation and protein levels were analyzed in WT, sac7, inp51, sac7 inp51, tax4 irs4 and sac7 tax4 
irs4 at 25 °C.  Analysis of (first panel) activated MPK1 with antibodies recognizing specific Thr/Tyr 
phosphorylation, and (second panel) MPK1 protein level with antibodies recognizing MPK1. 
 
The distribution of chitin is negatively regulated by INP51, TAX4 and IRS4 
To further investigate the regulation of MPK1 signaling by the INP51 complexes, we 
examined MPK1 readouts in sac7 inp51 and sac7 tax4 irs4 cells.  In particular, we 
examined the actin cytoskeleton, glucan synthase (FKS1) and chitin (see Introduction) in 
sac7, inp51, tax4 irs4, sac7 inp51 and sac7 tax4 irs4 cells grown at low (24°C) and high 
temperature (39°C).  Heat stress transiently depolarizes both the actin cytoskeleton and the 
glucan synthase (195).  The above mutant cells behaved like wild type cells with regard to 
the actin cytoskeleton and FKS1 (data not shown), suggesting that INP51, TAX4 and IRS4 
do not regulate signaling of the cell integrity pathway to these targets.  However, the 
amount and distribution of chitin was changed in some mutants.  In wild type cells, chitin is 
most visible at the neck and at a future bud site (Fig. 9).  In the sac7 and tax4 irs4 cells 
chitin distribution was slightly depolarized while in sac7 inp51 and sac7 tax4 irs4 cells we 
observed a striking increase in chitin signal and depolarization of chitin distribution.  In 
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sac7 inp51 and sac7 tax4 irs4 cells, the chitin was clearly distributed over the entire cell 
surface in unbudded cells, to the mother cell surface in small budded cells, and to both 
mother and daughter cell surfaces in large budded cells (Fig. 9).  The change in chitin 
amounts and distribution suggests that INP51, TAX4 and IRS4 regulate a specific branch of 
the cell integrity pathway affecting chitin. 
sac7
inp51
sac7 inp51Wild-type
tax4 irs4
sac7 tax4 irs4
Nomarski Chitin Nomarski Chitin
 
Figure 9 Chitin deposition is delocalized in sac7 inp51 deletion mutant and in sac7 tax4 
irs4 deletion mutant.  
Cells from logarithmically grown cultures (25 °C) were fixed with formaldehyde, and stained with 
calcuofluorwhite.  The cells were examined with Nomarski optics and by fluorescence to visualize the chitin. 
 
To investigate if the affect on chitin is the cause of the observed growth defect of 
sac7 inp51 and sac7 tax4 irs4 cells (Fig. 7), CHS3 was deleted in these mutants.  CHS3 
encodes chitin synthase III that is responsible for 90% of the chitin produced in the cell, 
although deletion of CHS3 does not cause a growth defect (294-296).  A deletion of CHS3 
in sac7 inp51 and sac7 tax4 irs4 mutants reduced the amount of chitin to wild type levels 
but did not suppress the growth defect (data not shown).  This suggests that targets of the 
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cell integrity pathway other than chitin could be affected (hyperactivated) and causing the 
growth defect observed in sac7 inp51 and sac7 tax4 irs4 cells. 
 
Discussion 
Here we present two proteins, TAX4 and IRS4, that are novel partners of the 
phosphoinositide 5-phosphatase INP51.  The structurally homologous and functionally 
redundant TAX4 and IRS4 proteins positively regulate INP51 activity, and thereby 
negatively regulate PI(4,5)P2 levels.  Furthermore, the INP51 complexes (INP51-TAX4 and 
INP51-IRS4) negatively regulate signaling through the cell integrity pathway including the 
MAP kinase MPK1. 
TAX4 and IRS4 contain an EPS15 homology (EH) domain.  EH domains are found 
mainly in proteins involved in endocytosis, organization of the actin cytoskeleton, or signal 
transduction, and interact specifically with short motifs containing an asparagine-proline-
phenylalanine (NPF) core.  INP51 contains an NPF motif (290) which is important for the 
interaction with TAX4 or IRS4, and which is not found in any other phosphoinositide 
phosphatase in Saccharomyces cerevisiae.  Thus, the interaction between INP51 and 
TAX4/IRS4 is similar to the interaction between the mammalian phosphoinositide 5-
phosphatase synaptojanin (NPF-containing) and EPS15, suggesting a conserved regulatory 
mechanism(71).  The functional consequence of EPS15 binding to synaptojannin is not 
known, but our findings suggest that this binding may result in activation of synaptojanin 
phosphatase activity.  
How does TAX4 or IRS4 activate INP51?  The EH domain has been suggested to 
play an important role in recruiting proteins to a specific cellular location(297).  Our studies 
did not reveal a change in INP51 localization in the absence of TAX4 and IRS4, suggesting 
that TAX4 and IRS4 regulate INP51 by a mechanism other than recruitment.  Furthermore, 
we did not detect a change in the binding of TAX4 or IRS4 to INP51 in response to several 
different types of cell wall stress, including heat shock and detergent treatment (data not 
shown).  Future studies will be required to determine the mechanism by which TAX4 or 
IRS4 activates INP51. 
We also present evidence that INP51, TAX4 and IRS4 genetically interact with two 
signaling pathways, the TORC2 signaling pathway and the cell integrity pathway.  The 
mechanism by which inp51 and tax4 irs4 mutations suppress the growth defect of a tor2 
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mutant remains unclear, but could be through the activation of the cell integrity pathway.  
The inp51 or tax4 irs4 mutations activate MPK1, and the cell integrity pathway is a 
downstream effector pathway of TORC2.  The activation of MPK1, which is detected only 
when inp51 or tax4 irs4 is combined with a sac7 mutation, could be a result of increased 
RHO1 activity (balance toward the active, GTP-bound form of RHO1).  The sac7 mutation 
eliminates a RHO1 GAP and thereby prevents down regulation of RHO1, whereas inp51 or 
tax4 irs4 causes an increase in the level of PI(4,5)P2 which could then activate RHO1 via 
the PH domain in the RHO1 GEFs. 
The combined action of a GAP (SAC7) and a phosphoinositide phosphatase 
(INP51) could be a conserved mechanism to achieve proper spatial and temporal regulation 
of a signaling pathway, in this particular case, signaling through the cell integrity pathway.  
The GAP and phosphoinositide phosphatase combination has been observed in other 
organisms such as Dictyostelium discoideum, where the phosphoinositide phosphatase 
Dd5P4 contains both a PI(4,5)P2 5-phosphatase catalytic domain and a GAP catalytic 
domain (20).  This domain combination is also present in the human PI(4,5)P2 5-
phosphatase OCRL1 that when mutated causes mental retardation and kidney and eye 
failure (oculocerebrorenal Lowe syndrome) (60,63,298). 
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Figure 10. Model showing INP51 complex regulating PI(4,5)P2 signaling linked to the 
cell wall integrity pathway.   
PI(4,5)P2 synthesis and turnover is regulated by MSS4 and INP51 respectively.  INP51 activity is controlled 
by TAX4 and IRS4.  PI(4,5)P2 signalling impinges on  PKC1 pathway controlled by two independent 
pathways, the TORC2 signaling pathway and cell wall integrity pathway. PI(4,5)P2 could signal to ROM2 or 
through an unknown parallel pathway. 
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5. CONCLUSION AND PERSPECTIVES 
 
Phosphorylated phosphoinositides (PPI) have been implicated in many cellular processes. 
Their essentiality has been shown by the implications of defective phosphoinositide 
metabolism in human disorders (34).  Despite the identification and characterization of 
many phosphoinositide kinases and phosphatases their regulation mechanisms are almost 
unknown.  However, the knowledge is increasing as exemplified by PI(3,5)P2 biosynthesis 
and signaling (124,127,128).  Further understanding how and when phosphoinositide 
kinases and phosphatases are regulated is therefore of great importance.  
Here we present that the activity of the PIP5K of Saccharomyces cerevisiae, MSS4, is 
regulated by calmodulin, CMD1, but the direct activating mechanism has not been 
elucidated.  Calmodulin is involved in many different cellular processes and the role of 
CMD1 and MSS4 signaling is most probably the organization of the actin cytoskeleton and 
endocytosis (249).  The effectors that link CMD1 and MSS4 signaling are not known but 
there are several putative targets binding PI(4,5)P2 and involved in the organization of the 
actin cytoskeleton such as actin-regulating proteins and GEFs (see 1.4.3).  Another 
possibility is the signaling to components of the cell wall integrity pathway and the TOR2 
signaling pathway since we observed link to PKC1.  These two pathways have in common 
the PH domain containing effector protein ROM2.  PI(4,5)P2 is localized to the entire cell 
periphery as visualized by the GFP-tagged PH domain of PLCγ (167).  However, ROM2 is 
localized only to the bud tip in small budded cells or to the bud-neck in larger budded cells.  
We observed the importance of PI(4,5)P2 levels for ROM2 localization.  This localization 
was also observed by (132) and is important for MSS4 signaling.  This indicates that the 
localization is mediated through lipid interaction but additional membrane interaction such 
as protein-protein interaction is probably needed.  Under active growing conditions 
PI(4,5)P2 could play a role in the recruitment of proteins to the plasma membrane together 
with protein-protein interaction as could be the case with the PI(4,5)P2-binding GEF 
ROM2.  However, the overexpression of this specific GEF is not able to suppress the 
growth defect upon loss of CMD1 function suggesting another link between CMD1 and 
MSS4. 
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To understand more about the complex PI(4,5)P2-signaling identification and 
characterization of proteins binding PI(4,5)P2 is needed.  More and more proteins are being 
identified revealing that not only the PH domain is important but also the ENTH domain.  
In addition, there is no clear consensus sequence for the PH domain making it difficult to 
identify all proteins containing PH domain and if the function of binding PI(4,5)P2 is 
conserved.  Interestingly, not all PH domains bind PI(4,5)P2 suggesting the necessity to 
define the three dimensional domain structure necessary for lipid binding as a tool for  the 
identification of proteins to find the exact PI(4,5)P2-binding module.  PI(4,5)P2 has been 
shown to only be present at the plasma membrane implicating that PH-containing proteins 
localized at or near the plasma membrane are more likely the targets of this particular lipid.  
Identification of additional PI(4,5)P2-binding proteins requires perhaps purification using 
PI(4,5)P2 as a bait.  This approach has been attempted by (299) identifying ARAP3 where 
PI(3,4,5)P3 was covalently linked to beads.  This method would also allow the identification 
of not yet defined lipid-binding domains.  This approach has been attempted several times 
but identifying very few proteins even if there are over 100 of proteins suggested to interact 
with PPI.  We also attempted to identify PI(4,5)P2-binding proteins by using PI(4,5)P2-
coupled beads but no interaction candidates were identified.   One reason could be the 
transient interaction with the PPI. 
PI(4,5)P2 has been shown to be both a regulator but also the precursor of messenger (IP3 
and DAG) making it difficult to distinguish between these two branches (7).  Nevertheless, 
the existence of domains specifically binding PI(4,5)P2 affirm the importance of this 
molecule.  On the other hand it is intriguing that in Saccharomyces cerevisiae that 
overexpression of MSS4 rescues the loss of the unique function of TOR2 (the organization 
of the actin cytoskeleton) while overexpression of PLC1 is able to rescue both the unique 
and the shared function (nutrient sensing) (179).  PLC1 and MSS4 have very different 
functions.  Whereas MSS4 is essential for proper organization of the actin cytoskeleton and 
endocytosis PLC1 has been implicated in completely different processes like Ca2+ signaling 
and nutritional and stress-related responses (146,147,173,177,184,300).  It will be of great 
interest to define the separate function of PI(4,5)P2 on the one hand and IP3 and DAG on 
the other hand in Saccharomyces cerevisiae to elucidate the distinct functions in the 
TORC2 signaling pathway.   
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The regulation mechanism of MSS4 remains unclear although there is evidence that MSS4 
performs a cytoplasm-nuclear shuttling (152).  It has been suggested that casein kinase I 
phosphorylates MSS4 which has also been observed in Schizosaccharomyces pombe 
(152,301).  However, the significance of MSS4 phosphorylation in PI(4,5)P2-signaling 
remains unclear.  In mammalian cells, PIP5K have been shown to interact with RHO, RAC 
and ARF isoforms but this has yet not been observed in yeast.  The identification of 
interactors might be dependent on specific conditions.  Indication that PI(4,5)P2 levels are 
regulated has been suggested previously by the fact that PI(4,5)P2-levels increase upon heat 
shock (147). 
The existence of specific PPI phosphatases suggest that these lipids need to be regulated as 
exemplified in mammalian cells.  The PI(4,5)P2 5-phosphatase synaptojanin 1 interacts with 
several proteins involved in the organization of the actin cytoskeleton and endocytosis such 
as amphiphysin (66).  There are several candidates for interaction with the synaptojanin-
like proteins in Saccharomyces cerevisiae such as the orthologue of amphiphysin RVS167 
but interactions has not been observed (302).  Here we present the synaptojanin-like INP51 
as a specific PI(4,5)P2 5-phosphatase that requires the presence of two EH domain 
containing proteins, TAX4 and IRS4 for its proper function.  Our study suggests that the 
INP51 complex might interact via the EH-domain of TAX4 and IRS4, with the NPF-motif 
of INP51 (data not shown).  The EH-NPF interaction is a conserved mechanism and in 
mammalian cells it is an important step in the targeting of proteins to specific cellular 
compartments (297).  In Saccharomyces cerevisiae the EH-containing proteins with known 
functions such as PAN1, END3 and EDE1 are involved in endocytosis and partly in the 
organization of the actin cytoskeleton (196,291,292).  In mammalian cells, the majority of 
the characterized EH-containing proteins such as EPS15 (interacts with synaptojanin 1), 
POB1 and intersectin 1 and 2 are involved in endocytosis and the organization of the actin 
cytoskeleton (303-305).  Besides the EH-NPF interaction being conserved our finding that 
the interaction component is PI(4,5)P2 phosphatase suggests a further common feature. 
In addition, we show that INP51 together with TAX4 and IRS4 negatively regulates the cell 
wall integrity pathway and the TORC2 signaling pathway.  This is opposed to MSS4 
function and in agreement to our model that MSS4 is responsible for the production of 
PI(4,5)P2 and INP51 for the turnover of PI(4,5)P2 (see model Fig 4.9).  The synthetic 
interaction observed in the sac7 inp51 mutant strongly implicates a dual negative regulation 
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of the cell wall integrity pathway.  This suggest that INP51 together with SAC7 is needed 
to control the cell wall integrity pathway to prevent excess cell wall synthesis which is 
observed in sac7 inp51 double mutants.  Interestingly, Dd5P4 is an inositol 5-phosphatase 
in Dictyostelium discoideum that contains a GAP domain important for its function (20).  
This domain combination is also present in humans, represented by the OCRL1 enzyme, 
suggesting that this mechanism, combination of GAP and 5-phosphatase activity, is 
conserved (60).  This two way-mechanism of regulation could have evolved to prevent 
signaling when not needed. 
In general, studies focusing in understanding PI(4,5)P2-signaling and regulation in 
mammalian cells could give insights how for example plasma membrane signaling 
pathways involved in the remodelling of the actin cytoskeleton could be used as a tool to 
inhibit uncontrolled migration of malignant tumor cells (18).  More specifically to the 
model organism Saccharomyces cerevisiae, future studies will be required to determine 
upstream signals of the INP51 complex as well as the direct targets of PI(4,5)P2-signaling.  
Increased knowledge in the construction mechanism of the fungal cell wall would also give 
insights in further development of new antifungal compounds (190). 
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